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Abstract
 The human brain is a network of ninety billion neurons that allows for many of the 
behavioral adaptations considered unique to our species. One-fifth of these neurons are layered 
in an epithelial sheet known as the cerebral cortex, which is exquisitely folded into convolutions 
called gyri. Defects in neuronal number clinically present with microcephaly (Greek for “small 
head”), and in inherited cases these defects can be linked to mutations that identify genes 
essential for neural progenitor proliferation. Most microcephaly genes are characterized to play a 
role in the centrosome, however rarer presentations of microcephaly have identified different 
mechanisms.
 Charged multivesicular body protein/Chromatin modifying protein 1A (CHMP1A) is a 
member of the ESCRT-III endosomal sorting complex, but is also suggested to localize to the 
nuclear matrix and regulate chromatin. We show that loss-of-function mutations to human 
CHMP1A cause a rare microcephaly syndrome with reduced cerebellar volume. CHMP1A 
mutant cells show impaired proliferation, with increased expression of INK4A, a negative 
regulator of stem cell proliferation, and loss of enrichment of INK4A promoter DNA in 
chromatin immunoprecipitations performed against BMI1, indicating a loss of the normal 
repression of INK4A by BMI1. Defects in zebrafish produced by morpholino-based knockdown 
of the CHMP1A orthologue resembled those seen after bmi1 knockdown, and were partially 
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rescued by INK4A orthologue knockdown. Chmp1a is expressed in dividing cells in the 
developing cerebral cortex and cerebellar external germinal layer, and in vitro knockdown assays 
using short hairpin RNA implicate a role in Wnt- and Shh-pathway signal transduction. 
Altogether, this suggests that CHMP1A serves as a critical link between cytoplasmic and nuclear 
signals that regulate neural progenitor proliferation.
 Compared to microcephaly, polymicrogyria is a more heterogeneous brain malformation 
that has been suggested to implicate molecular mechanisms involved in pattern formation in the 
cortex. Many cases of polymicrogyria show an asymmetric distribution, and we demonstrate that 
these cases are strongly biased towards a right-predominant pattern. Using whole-exome 
sequencing in patients with polymicrogyria, we identify rare mutations in two primary 
microcephaly genes, ASPM and WDR62. Interestingly, some of these patients lack profound 
microcephaly, suggesting heretofore underappreciated pleiotropic effects of these centrosomal 
genes.
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Introduction
 We attribute many of the features that are most quintessentially human to adaptations that 
occurred in the brain. Grammatical language, technological innovation, and consciousness are all 
cognitive capacities that are unique to our species, or at the very least are sophisticated upgrades 
of more primitive capacities seen in primates: basic communication, tool use, and self-
awareness. Whether these human adaptations are a direct product of natural selection, or 
evolutionary “spandrels” that emerged from more proximate selective forces (Gould and 
Lewontin, 1979), the substrate for these phenotypes resides in the information processing of a 
very large brain. The human brain consists of nearly ninety billion neurons and an approximately  
equal number of nonneuronal cells (Azevedo et al., 2010). One-fifth of these neurons are layered 
in an epithelial sheet known as the cerebral cortex, which is exquisitely folded inside the cranium 
in convolutions called gyri. The expansion of the size of the cerebral cortex is perhaps the 
cardinal feature that distinguishes modern humans from our primate ancestors. It is generally 
assumed that the size of the cerebral cortex is a proxy for the computational power of the brain, 
because of the apparent modularity of the cortical circuit (Hill and Walsh, 2005). Therefore, an 
essential scientific inquiry concerning the existential nature of the human brain is to understand 
the developmental processes and molecular mechanisms necessary for this expansion and 
folding.
 In the 7-8 million years since humans diverged from the last common ancestor with 
chimpanzees, our brains expanded approximately threefold (Hill and Walsh, 2005). Strikingly, 
the size of the human brain nearly doubled compared to the early hominids of 2-2.5 million years 
ago (Carroll, 2003). However these measurements are based on brain mass relative to body mass, 
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and can be confounded by the large variation in body mass seen in primates and early hominids 
(Marino, 1998). When compared to a mouse, the relative brain size of a human (reported as the 
“encephalization quotient”) is increased by approximately 15-fold (Fish et al., 2008). 
Suspiciously clean estimates of 100 billion neurons and one trillion glial cells in the human brain 
are strewn throughout the literature, though based on scant evidence (Kandel et al., 2000; Noctor 
et al., 2007). Estimates in neuronal number based on counts from histological sections offer a 
very wide range of possibilities, anywhere between 75 and 125 billion neurons in the cerebral 
cortex and cerebellum (Pelvig et al, 2008; Andersen et al., 1992). Moreover, when compared 
between orders, these estimates do not correct for the fact that human neurons are larger than 
mouse neurons, and so a larger brain does not automatically infer more neurons (Herculano-
Houzel et al., 2007). Recent studies using more precise single-cell counting techniques with 
molecular markers have revised the estimate of neurons in the adult human brain downward, to 
roughly ninety billion (Azevedo, 2010). When compared to other primates using the same 
technique, the human brain is approximately ten percent larger than a linearly scaled-up version 
of a theoretical 75 kg primate’s brain (Azevedo, 2010). While this ten percent increase is 
significant and may account for the remarkable emergent capacities of the human brain, it 
nevertheless is a more modest reassessment of recent human brain expansion.
Developmental steps for expanding the mammalian neuroepithelium
 The increased size of the human cortex reflects not only an increase in neuronal number, 
but also added complexity to the basic cortical circuit diagram, most notably an expansion of 
upper cortical layers (Marin-Padilla, 1992). The basic six-layered neocortex evolved during the 
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transition from reptiles to mammals, prior to the dramatic increase in cortical surface area 
(Nieuwenhuys et al., 1999). Although the increased thickness of the upper layers of the human 
cerebral cortex is apparent, the expansion of the cortex predominantly reflects an increase in 
surface area (Caviness et al., 1995; Rakic, 1995). This evolutionary expansion in neuronal 
number is due to an increase in the number of rounds of progenitor cell proliferation. Cortical 
progenitors undergo eleven rounds of cell division in mice, approximately thirty in rhesus 
macaque, and more rounds in humans (Takahashi et al., 1999; Kornack and Rakic, 1998). 
Neuronal number and the direction of cortical expansion (lateral vs. radial) are determined not 
only by the number of progenitor cell divisions, but also the mode of division -- either symmetric 
or asymmetric. Symmetric divisions give rise to two identical cells equipotent in their self-
renewal capacity, whereas asymmetric divisions yield one stem cell and one daughter cell with a 
more restricted cell fate potential (Morrison et al., 2006).
 In the developing neuroepithelium of invertebrates, earlier evidence suggested that the 
fate of daughter cells of neural progenitors is exquisitely sensitive to the orientation of the 
mitotic spindle. At the onset of neurogenesis, apical neural progenitors divide symmetrically 
(Rakic, 1988). In these divisions, the mitotic spindle is oriented parallel to the neuroepithelium, 
resulting in an exponential expansion of the neural progenitor pool (Chenn and McConnell, 
1995). Following the proliferative phase, the neural progenitors enter an asymmetric phase. In 
these divisions, the mitotic spindle rotates vertically until it is perpendicular to the plane of the 
neuroepithelium, yielding one neuron and one renewed neural progenitor (Chenn and 
McConnell, 1995; Haydar et al., 2003). The postmitotic neuron then migrates along a radial glial 
apical-basal process until it reaches its specified destination in the cortex, while the neural 
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progenitor remains at the apical surface to continue dividing (Noctor et al., 2004). Consistent 
with the finding that cleavage plane orientation affects daughter cell fate, several proteins are 
found to be asymmetrically inherited during neurogenic divisions -- including Notch (Chenn and 
McConnell, 1995), Numb (Cayouette et al., 2001), and Minibrain (Hammerle et al., 2002). Even 
the apical plasma membrane, and its transmembrane protein constituents (such as members of 
the Par family), are apparently asymmetrically distributed between the two daughter cells during 
vertical cleavage plane divisions (Kosodo et al., 2004). Hence, a putative mechanism appears to 
exist whereby asymmetric inheritance of neural progenitor cell components -- as a result of 
vertical orientation of the mitotic spindle -- confers different fates to the daughter cells. 
 However, there is some controversy whether mitotic spindle orientation determines 
whether progenitors in the VZ undergo symmetric or asymmetric cell divisions in mammals. 
Through time-lapse imaging of rat neocortical precursor cells, cleavage plane orientation was not 
necessarily associated with daughter cell fate, as previously thought (Noctor et al., 2008). Radial 
glial cells divided either symmetrically or asymmetrically depending on the stage of 
neurogenesis, despite generally dividing with ‘vertical’ cleavage planes oriented perpendicular to 
the ventricular surface (Noctor et al., 2008).
 There are other paradigms besides spindle orientation that could underlie asymmetry of 
progenitor cell divisions. The ‘mother centriole hypothesis’ postulates that asymmetric 
inheritance of centrosomes in dividing radial glial progenitors determines which of two daughter 
cells will remain a progenitor and which will eventually differentiate into a neuron (Wang et al., 
2009). In this model, the daughter cell that inherits the older mother centriole remains in the 
progenitor pool while the other daughter cell differentiates into a neuron.
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 Two classes of neural progenitor cells can be distinguished based on their location during 
mitosis: apical and basal progenitors. Apical progenitors (APs) are located in a pseudostratified 
layer bordering the lateral ventricle, known as the ventricular zone (VZ). APs share the 
characteristics seen in all epithelial cells: apical junctional complexes, and apicobasal bipolar 
morphology (the presence of apical and basal processes) (Fishell and Kreigstein, 2003; Huttner 
and Kosodo, 2005). In APs, the apical process contacts the ventricle directly, often presenting a 
primary cilium (Alvarez-Buylla et al., 1998; Gerdes et al., 2008). APs also migrate in a dynamic 
pattern called “interkinetic nuclear migration”, in which the nucleus moves perpendicular to 
apical plane in synchrony with the cell cycle, migrating apically during the G2 phase of the cell 
cycle and undergoing mitosis only when the nucleus is at the apical surface (Messier, 1978; 
Takahashi et al., 1993). This continuous process during early neural development is what gives 
the VZ its pseudostratified appearance. 
 Basal progenitors (BPs) constitute the second class of neural progenitors in mammals, 
and are also known as “intermediate” or “subventricular zone” (SVZ) progenitors for their 
location in relation to the VZ (Kriegstein et al., 2006; Noctor et al., 2004). BPs arise from a 
slightly asymmetric apical divisions, migrate basally and retract their apical process before 
mitosis (Liu et al., 2008). BPs are found almost exclusively in the telencephalon and are only 
rarely observed in the hindbrain or spinal cord (Haubensak et al., 2004). In the telencephalon, 
BPs are generated from the onset of neurogenesis and increase in number as neurogenesis 
proceeds, eventually accumulating to form a secondary germinal layer, the SVZ. BPs have a 
round, non-polar morphology, and mostly divide symmetrically in one terminal division to form 
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two post-mitotic neurons (Haubensak et al., 2004; Miyata et al., 2004; Noctor et al., 2004; 
Attardo et al., 2008; Noctor et al., 2008).
 Multiple subclasses of apical and basal progenitors have been identified and classified 
based on a combination of molecular markers, however a detailed description of these subtypes 
is outside the scope of this thesis. Briefly, one class of basal progenitors -- outer radial glia 
(oRG) -- have been identified predominantly in the primate brain, and characterized by an RG-
like morphology but laking an apical process (Hansen et al., 2010). oRG do not express apically 
localized membrane proteins such as CD133, Par3, or aPKCl (Fietz et al., 2010), and divide 
asymmetrically in a horizontal cleavage plane to produce an oRG that retains the basal fiber, and 
a daughter cell that lacks a pial contact (Hansen et al., 2010).  These daughter cells and oRGs 
form the outer subventricular zone (OSVZ), a region that arises late in primate neurogenesis but 
expands rapidly to become the dominant germinal layer in the neocortex (Lui et al., 2011). 
Whereas in rodents asymmetric divisions of the ventricular RG produce almost all of the neurons 
of the adult brain, in primates (including humans) the outer RG and OSVZ transit-amplifying 
cells are responsible for the dramatic expansion of brain size (Lui et al., 2011).
 An intriguing correlation across different animals is that the presence of a sizeable OSVZ 
germinal layer correlates with having a gyrencephalic brain. Gyri are the intricate and 
reproducible folds of the neuroepithelium that maximizes the amount of cortical surface area that 
can be packed into a fixed volume. Gyri are not limited to primates; indeed, the feature appears 
in multiple different clades, including monotremes, marsupials, and placentals (Kriegstein, et al., 
2006). While this suggests that the gyrencephalic cortex arose independently in multiple 
lineages, there might have been similar underlying mechanisms in each instance. An increase in 
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the number of RG, or an increase in the number of symmetric divisions, could expand the 
progenitor pool and pack more neuroepithelium into a limited cranial space. When mouse 
neuroepithelial cells were engineered to express a constitutively active form of β-catenin (a 
positive regulator of neural stem cell proliferation via the WNT signaling pathway), more neural 
progenitors were generated, as expected, and remarkably the mice developed an increased 
cortical surface area that displayed folds suggestive of gyri (Chenn and Walsh, 2002). The 
surface area of the lateral ventricles was also increased, consistent with the hypothesis that 
expansion of the VZ progenitors through lateral divisions increased both the neuronal number 
and ventricular surface area. By contrast, it has been suggested that expansion of the basal 
germinal layer, such as oRGs and OSVZ transit-amplifying cells, would allow for gyrification 
without expansion of lateral ventricle neuroependyma (Lui et al., 2011).
  
 Proper sizing of the cortex is highly sensitive to precise control of the quantity and type 
of neural progenitor proliferation. The timing of the switch from symmetric to asymmetric 
divisions during neurogenesis is critical to ensure appropriate expansion of the neural progenitor 
pool. One way of quantifying this transition is by measuring cell cycle exit fraction, or the ratio 
of cells exiting the cell cycle, to cells remaining in the progenitor pool (Q/P ratio), at each 
progenitor cell division (Takahashi et al., 1996). Manipulating cell cycle exit fraction to delay 
this switch, by stably overexpressing β-catenin in neural progenitors, has been shown to lead to 
an expanded cerebral cortex (Chenn and Walsh, 2002). On the other hand, prematurely switching 
from symmetric to asymmetric divisions, such that the cell cycle exit fraction is higher at earlier 
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stages of neurogenesis, depletes the progenitor pool, leading ultimately to a smaller cortex (Chae 
and Walsh, 2007; Feng and Walsh, 2004). 
 Inherited or acquired mutations that disrupt the molecular processes critical for neural 
progenitor proliferation often manifest as profound brain malformations. Detailed clinical, 
pathological, and radiographic interrogation of these brain malformations allows for specific 
mechanistic hypotheses into role of the specific genes identified by the genetic mapping. Many 
of these disorders fall under the broad classification of “microcephaly”.
Microcephaly
 Microcephaly, Greek for “small head”, is clinically defined as a head circumference less 
than two standard deviations below the mean for the person’s age and gender (Mochida and 
Walsh, 2004).  It is a genetically heterogeneous disorder, with each individual genetic cause 
being relatively rare, but collectively affecting approximately one percent of all Americans 
(Mochida and Walsh, 2001).  The condition is subclassified into primary microcephaly, which 
presents at birth, and secondary microcephaly, which develops postnatally (Woods, 2004).  This 
clinical distinction translates to a functional difference -- primary microcephaly is typically a 
developmental defect, while secondary microcephaly is typically neurodegenerative or due to 
some other progressive process (Dobyns, 2002).  In autosomal recessive primary microcephaly 
(MCPH), the brain is small but architecturally normal, which implies a decrease in neural 
progenitor cell number (Woods, et al. 2005).  At least seven genes have been identified as causes 
of primary autosomal recessive microcephaly (MCPH): MICROCEPHALIN, WDR62, 
CDK5RAP2, CEP152, ASPM, CENPJ and STIL (Bilguvar et al., 2010; Bond et al., 2002; Bond 
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et al., 2005; Guernsey et al., 2010; Jackson et al., 2002; Kumar et al., 2009). In all seven genes, 
microcephaly is the loss-of-function (or null) phenotype.  All of these genes are expressed in the 
VZ of the embryonic mouse brain, and peak in expression during the period of neurogenesis 
(Bond and Woods, 2006).  Furthermore, these genes implicate the critical role of mitotic spindle 
orientation and cell cycle timing in proper maintenance of the neural progenitor pool.
 Cdk5rap2 and Nde1 mutant mice are models of microcephaly. Nde1 homozygous mutant 
mice, which are profoundly microcephalic, show defects in spindle orientation within 
progenitors. They also show an increased cell cycle exit fraction between E14.5 and E15.5, 
leading to a cell-fate change with generation of fewer superficial-layer neurons and more deep-
layer neurons. A slight increase in apoptosis is observed (Feng and Walsh, 2004). Likewise, 
Cdk5rap2 homozygous mutant mice show defects in spindle orientation within VZ progenitors, 
as well as premature cell cycle exit and resulting depletion of superficial-layer neurons. Unlike 
the Nde1 mutant mice, the Cdk5rap2 mutant mice show only a modest increase in deep-layer 
neurons and a significant increase in apoptosis (Lizarraga et al., 2010). While both studies show 
a correlation between spindle orientation defects and changes in cell cycle exit fraction, neither 
demonstrates a causal relationship between the two. 
 ASPM has also been implicated in regulating mitotic spindle orientation. Loss-of-function 
of Asp, the Drosophila homolog of ASPM, led to disorganization of gamma-tubulin ring 
complexes and disruption of microtubule organizing center (MTOC) activity (do Carmo Avides 
and Glover, 1999; Wakefield et al., 2001). Spindle orientation defects were observed with ASPM 
RNAi in cultured human U2OS osteosarcoma cells (Higgins et al., 2010). A mouse Aspm RNAi 
study using in utero electroporation also suggested spindle orientation defects (Fish et al., 2006). 
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However, analysis of Aspm homozygous mutant mice revealed no changes in spindle orientation 
or the ratio of symmetric to asymmetric cell divisions in the neuroepithelium (Pulvers et al., 
2010). 
 Alternatively, ASPM may affect proliferation by acting on the Wnt signaling pathway 
rather than spindle orientation. Wnt signaling promotes neural progenitor proliferation (Chenn 
and Walsh, 2002), and a genome-wide siRNA screen identified ASPM as a positive regulator of 
Wnt signaling (Major et al., 2008). In vivo RNAi of Aspm in the developing mouse cortex causes 
proliferation defects, which are rescued by co-expression of stabilized β-catenin (Buchman et al., 
2011). These findings suggest that the Wnt pathway may mediate defects in neurogenesis 
associated with ASPM loss-of-function, with possible implications for other MCPH genes. 
 Mitotic spindle orientation is not the only paradigm to explain microcephaly.  In addition 
to the seven MCPH genes, two genes have been identified for other autosomal recessive 
disorders in which microcephaly is a predominant feature among other distinguishing 
radiological abnormalities.  Both of these genes -- COH1 and ARFGEF2 -- implicate the role of 
vesicle-mediated intracellular protein transport in neural progenitor proliferation (Kolehmainen 
et al., 2003; Sheen et al., 2004), though the detailed mechanisms are not understood.  It is 
interesting to note that CHMP1A, a new gene we have discovered for a subtype of microcephaly, 
appears to have roles in both neural progenitor proliferation and endosomal vesicle transport.
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Introduction
 Charged multivesicular body protein 1A/Chromatin modifying protein 1A (CHMP1A) is 
a member of the ESCRT-III (endosomal sorting complex required for transport-III) complex 
(Howard et al., 2001; Tsang et al., 2006), but is also suggested to localize to the nuclear matrix 
and regulate chromatin structure (Stauffer et al., 2001).  Here we show that loss-of-function 
mutations to human CHMP1A cause reduced cerebellar size (pontocerebellar hypoplasia) and 
reduced cerebral cortical size (microcephaly). CHMP1A mutant cells show impaired 
proliferation, with increased expression of INK4A, a negative regulator of stem cell proliferation, 
and a loss of enrichment of INK4A promoter DNA in chromatin immunoprecipitations performed 
against BMI1, indicating a loss of the normal repression of INK4A by BMI1. Defects in zebrafish 
brain produced by morpholino-based knockdown of the zebrafish CHMP1A orthologue 
resembled those seen after bmi1 knockdown, and were partially rescued by INK4A orthologue 
knockdown, further supporting links between CHMP1A and BMI1-mediated regulation of 
INK4A. Chmp1a is expressed in dividing cells in the developing cerebral cortex and cerebellar 
external germinal layer, suggesting that CHMP1A serves as a critical link between cytoplasmic 
signals and BMI1-mediated chromatin modifications that regulate proliferation of CNS 
progenitor cells.
As part of ongoing studies of human disorders of neural progenitor proliferation, we 
identified three families characterized by underdevelopment of the cerebellum, pons, and 
cerebral cortex. In a consanguineous pedigree of Peruvian origin, three children in two branches 
were affected (Figure 2.1a, b, e; Family 1). Two additional pedigrees from Puerto Rico showed 
27
similar pontocerebellar hypoplasia and microcephaly (Figure 2.1c, d, e; Family 2 and 3). Brain 
MRI of affected individuals from all families show severe reduction of the cerebellar vermis and 
hemispheres. Strikingly, the cerebellar folds (“folia”) are relatively preserved despite the 
extremely small cerebellar size (Figure 2.1a-d, Figure 2.2, Figure 2.3). All affected individuals 
had severe pontocerebellar hypoplasia, though affected individuals in Family 1 showed better 
motor and cognitive function than those in Family 2 and 3 (See Supplementary Note 1, at end 
of chapter). 
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Figure 2.1
Brain MRI and linkage mapping of pontocerebellar hypoplasia with microcephaly. 
(a-d) T1-weighted sagittal brain MRI images of an age-matched, neurologically normal 
individual (a) and affected individuals CH3102 (b), CH2402 (c), and CH2701 (d) are shown. 
Compared to control, affected individuals show mild reduction in cortical volume, thinning of 
the corpus callosum, and severe hypoplasia of the pons, vermis, and cerebellar hemispheres. (e) 
Family 1 is a consanguineous pedigree from Peru in which three children from two branches are 
affected. Family 2 and 3 are both from Puerto Rico. Below each child in Family 1 and 2 is their 
Affymetrix 250K Sty SNP data (red and blue = homozygous SNP call; yellow = heterozygous 
SNP call), showing a region of homozygosity shared by all affected individuals in distal 
chromosome 16q. The graph aligned with the SNP genotyping data shows multipoint LOD 
scores calculated from microsatellite maker analysis of Family 1. Genes in the region of LOD > 
3 are indicated on the right of the graph.
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Figure 2.1 (Continued)
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Figure 2.2 
T1-weighted sagittal MRI from CH2402.
The extent of the cerebellar hypoplasia is most evident near the midline planes, around image 
9-10.
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Figure 2.3
T1-weighted sagittal MRI from CH3102.
The extent of the cerebellar hypoplasia is most evident near the midline planes, around image 
11-12.
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Genome-wide linkage analysis of Family 1 and 2 using single nucleotide polymorphism 
(SNP) microarrays implicated only one region on chromosome 16q as linked and homozygous in 
all six affected individuals (Figure 2.1e; Figure 2.4), with a maximum multipoint LOD score of 
3.68 (Figure 2.1e). Although Families 2 and 3 are not highly informative for linkage analysis, 
their shared homozygosity provides additional support for this locus. Furthermore, Families 2 
and 3 shared the same haplotype (Figure 2.4), suggesting a founder effect. Sequencing of 42 
genes within the candidate interval on 16q24.3 revealed homozygous variants predicted to be 
deleterious only in the CHMP1A gene. CHMP1A consists of seven exons encoding a 196 amino 
acid protein (See Supplementary Note 2, at end of chapter). Affected individuals in Family 2 
and 3 had a homozygous nonsense variant in exon 3, predicted to prematurely terminate 
translation (c.88C>T; Q30X; Figure 2.5a). Family 1 showed a homozygous variant in intron 2 of 
CHMP1A (c.28-13G>A; Figure 2.5a) predicted to create an aberrant splice acceptor site leading 
to an 11 base pair insertion into the spliced mRNA product (Figure 2.6a). The two mutations 
were absent from dbSNP, 281 neurologically normal European control DNA samples (562 
chromosomes), the 1000 Genomes Project database, and approximately 5000 control exomes 
from the NHLBI Exome Sequencing Project. We sequenced CHMP1A in 64 patients with other 
cerebellar anomalies without finding additional mutations, but none of these patients shared the 
rare and distinctive pattern of hypoplasia seen in CHMP1A mutant patients. 
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Figure 2.4
Microsatellite marker haplotypes in the region of linkage on chromosome 16 in Families 1, 
2, and 3.
The affected individuals in Family 1,2 and 3 share a region of homozygosity on chromosome 
16q24.3. Family 2 and 3 have the same homozygous haplotype. The minimal critical interval is 
defined by D16S689 and 16qter.
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Figure 2.5
Loss-of-function mutations in CHMP1A, and dysregulation of INK4A in patient cell lines.
(a) Chromatograms of genomic DNA sequencing show homozygous mutations in intron 2 
(patient CH3101; c.28-13G>A) and in exon 3 (patient CH2401; c.88C>T). (b) A schematic 
diagram of full length CHMP1A, showing the relative contribution of each exon to the 196 
amino acids of the protein. The expected effect of the mutation in CH2401 is a premature 
termination of translation after 29 amino acids. The intronic mutation in CH3101 creates a novel 
splice acceptor site, resulting in a termination of translation after 36 amino acids. (c) Western 
blot analysis of lysates from lymphoblastoid cell lines from CH2401 and CH3101 demonstrates a 
complete loss of expression of a 24 kD band detected by a CHMP1A antibody in control lysate 
(CTRL). Lysates from a cell line generated from the mother of CH3101 (CH3103) shows 50% of 
protein level relative to control. (d) Lymphoblastoid cell lines from patients CH2401 and 
CH3101 proliferate at a much lower rate compared to control cell lines. (e) qPCR of cDNA 
levels from human lymphoblastoid cell lines from patients CH2401 and CH3101 show a nearly 
two-fold increase in expression of INK4A relative to an unrelated, neurologically normal control 
cell line (normalized to GAPDH expression levels). The other transcribed isoform at the locus, 
ARF, shows no significant difference in expression level between patient cells and control. (f) 
ChIP-qPCR from lymphoblastoid cell lines using a BMI1 antibody shows an approximate eight-
fold enrichment of INK4A promoter DNA relative to probes targeted 10kb upstream (10kb US) 
of the locus in a control cell line. This enrichment is reduced by nearly half in cell lines derived 
from a patient with a homozygous mutation in CHMP1A (CH2401). However, enrichment at the 
ARF promoter is not significantly different from the control cell line.
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Figure 2.6
Analysis of aberrant splicing due to the intronic mutation in Family 1.
(a) NetGene2 (Brunak et al., 2001) web-based prediction was performed on the region 
surrounding the intron 2-exon 3 junction of CHMP1A, with and without the presence of the 
nucleotide change found in Family 1 (c.28-13G>A). Confidence values for predicted splice 
acceptors are scaled from zero to one, with a higher number indicating a greater probability of 
being a splice acceptor. In the wildtype sequence (WT), the annotated acceptor is predicted with 
a high confidence value (0.83). A cryptic splice acceptor 21 bp upstream of the annotated 
acceptor is also predicted (0.76). In the presence of the mutation (CH3101), the confidence value 
for the annotated acceptor decreases (0.69), and a novel acceptor 11 bp upstream is predicted 
(0.43). The confidence value for the cryptic acceptor 21 bp upstream is not affected the presence 
of the mutation. (b) CHMP1A cDNA from lymphoblastoid cell lines were sequenced. A control 
sample (CTRL) reveals a single transcript, which utilizes the annotated splice acceptor. An 
affected individual (CH3101) does not show any wildtype transcript, and instead reveals a 
transcript that utilizes the novel acceptor 11 bp upstream of the annotated acceptor (resulting in a 
11 bp insertion), as well as a transcript that utilizes the cryptic acceptor 21 bp upstream of the 
annotated acceptor (resulting in a 21 bp insertion).  The mother of CH3101 (CH3104) shows a 
similar tracing to control, suggesting that the abnormal transcripts are quite unstable.
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RT-PCR analysis of CHMP1A in lymphoblastoid cells from affected individuals from 
Family 1 (CH3101 and CH3105) identified the predicted aberrant transcript with the 11 base pair 
insertion and a second aberrant transcript with a 21 base pair insertion, but no normal CHMP1A 
transcript (Figure 2.6b). In the parents of affected children Family 1, and in unaffected control 
samples, only the normal transcript was detected, suggesting that the abnormal splice products 
are unstable. Western blot analysis revealed a single 24 kilodalton band in a normal control 
individual, but no corresponding band was detected in affected individuals from Families 1 or 2 
(CH3101 and CH2401, respectively; Figure 2.5c). Normalized to the loading control, levels of 
CHMP1A were 50% in the parent (CH3104). Hence this genetic study establishes CHMP1A null 
mutations as the cause of pontocerebellar hypoplasia and microcephaly in these pedigrees. 
CHMP1A has been assigned two distinct putative functions, as both a chromatin 
modifying protein, and a charged multivesicular body protein (Howard et al., 2001; Stauffer et 
al., 2001). CHMP1A was originally identified as a binding partner of the Polycomb group 
protein Pcl (Polycomblike) (Stauffer et al., 2001). In the nucleus, it has been suggested to recruit 
the Polycomb group transcriptional repressor BMI1 to heterochromatin, and overexpressed 
CHMP1A has been shown to arrest cells in S-phase (Stauffer et al., 2001). In the cytoplasm, 
CHMP1A is part of the ESCRT-III complex (endosomal sorting complex required for transport) 
Howard et al., 2001; Tsang et al., 2006). ESCRT-III complex localizes to endosomes and 
interacts with VPS4A and VPS4B (Stuchell-Brereton et al., 2007) to assist in the trafficking of 
ubiquitinated cargo proteins to the lysosome for degradation (Scita et al., 2006).  
We investigated potential relationships of CHMP1A to Polycomb function by analysis of 
cell lines from two patients harboring different CHMP1A mutations (CH3101 from Family 1, 
39
and CH2401 from Family 2), which show severely impaired doubling times compared to control 
cell lines, suggesting essential roles of CHMP1A in regulating cell proliferation (Figure 2.5d). In 
order to examine BMI1 function in these cells, we performed quantitative PCR analysis of 
expression of the BMI1 target locus CDKN2A, which in human encodes alternative transcripts 
INK4A and ARF. This revealed abnormally increased expression of INK4A, the isoform 
implicated in cerebellar development, but not of ARF (Figure 2.5e), suggesting de-repression of 
INK4A. Chromatin immunoprecipitation with a BMI1 antibody in control cell lines showed an 
approximately eight-fold enrichment of BMI1 binding at INK4A promoter DNA, relative to a 
control region 10kb upstream, whereas cells from an affected individual (CH2401) showed only 
about half this effect (Figure 2.5f). Enrichment of BMI1 at the ARF promoter was not substantial 
in this assay, and was similar in both control or patient cell lines, consistent with the specificity 
of regulation of the INK4A isoform by BMI1 (Figure 2.5f). Bmi1 suppresses the Cdkn2a locus 
via Polycomb-mediated H2A monoubiquitination, and is required for neural stem cell self-
renewal (Molofsky et al., 2003). Our evidence suggests a role for CHMP1A in mediating BMI1-
directed epigenetic silencing at the INK4A promoter, but not at the ARF promoter.  
We further explored the relationship between CHMP1A and BMI1 using morpholino-
based knockdown experiments in zebrafish. Knockdown of the zebrafish CHMP1A orthologue 
(chmp1a) resulted in reduced cerebellum and forebrain volume, similar to the effects of human 
CHMP1A mutations and zebrafish knockdown of BMI1 orthologues (Figure 2.7a-e). The 
cerebellum consists of 5 major cells types, with the principal cell, known as the Purkinje cell, 
deriving from the ventricular epithelium, whereas granule cells derive from a separate progenitor 
pool known as the rhombic lip. Granule cell precursors then migrate over the outer surface of the 
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cerebellum and form the external germinal layer (EGL) before migrating radially past the 
Purkinje cells to settle in the internal granule layer (IGL) (Garel et al., 2011).)Within)the chmp1a 
morphant cerebellum, the internal granule and molecular layers were severely affected (Figure 
2.7a,b), which is consistent with the relatively preserved folia pattern of the human cerebellum 
(thought to be primarily established by Purkinje cells) and severely reduced volume (determined 
mainly by granule cell quantity). 
Next, we tested genetic interactions between chmp1a and the zebrafish orthologue of 
INK4A (ink4a).  Knockdown of ink4a alone did not result in noticeable abnormalities, and 
double knockdown of chmp1a and ink4a resulted in partial rescue of the brain morphology 
defects seen with chmp1a knockdown (Figure 2.7f,g). This was analogous to the rescue of the 
Bmi1 knockout mouse cerebellar phenotype seen in the Bmi1 and Cdkn2a double knockout mice 
(Jacobs et al., 1999). Of note, there are also parallels in brain morphology between individuals 
with CHMP1A mutations and Bmi1-deficient mice, which show cerebellar hypoplasia (Leung et 
al., 2004; van der Lugt et al., 1994) (Figure 2.7h,i).  In Bmi1-null mice, the cerebellar 
architecture was generally preserved, but the thickness of the granular and molecular layers was 
markedly reduced (Leung et al., 2004), and Bmi1-deficient mice show a modest reduction in 
cerebral volume (Leung et al., 2004; Zencak et al., 2005), similar to CHMP1A mutant patients 
(Supplementary Note 1, at end of chapter).
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Figure 2.7
Genetic links between CHMP1A and BMI1 in zebrafish and mice.
(a, b) Compared to parasagittal section of control zebrafish 5 days post fertilization (a), zebrafish 
injected with chmp1a morpholino (MO) show a reduction in cerebellum)and)forebrain)volume. 
Higher magnification images of the cerebellum (insets) highlight loss of molecular and internal 
granular layers in the mutant (arrowheads). (c-g) Compared to control zebrafish (c), morpholino-
based knockdown of chmp1a (d) shows a reduction in head size, with the hindbrain more 
markedly reduced in thickness (asterisks), which is similar to the phenotype seen by knocking 
down the zebrafish orthologues of BMI1, bmi1a and bmi1b (e). When the ink4a morpholino is 
co-injected with the chmp1a morpholino, the chmp1a knockdown phenotype is partially rescued 
(f). Embryos were classified at 28 hours post fertilization as either normal, disrupted, or severely 
disrupted (see Online Methods) for each of uninjected controls, ink4a MO, bmi1 MO chmp1a 
MO, bmi1 MO coinjected with ink4a MO, and chmp1a MO coinjected with ink4a MO or human 
CHMP1A mRNA. (g). (h, i) Compared to the wildtype mouse cerebellum at P25 (h), sagittal 
cross-sectional area of the Bmi1-/- mouse cerebellum at the same age (i) is dramatically reduced, 
though foliation and structure of the lobules (indicated in Roman numerals) are generally 
preserved. Scale bars = 200µm (a, b), 200µm (c-f), 500µm (h, i).  Asterisk = p < 0.0001, two-
tailed Pearson’s chi-squared test.
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 Though Chmp1a immunoreactivity is predominantly cytoplasmic, some nuclear 
localization is seen in some cell types. Confocal images of NIH 3T3 cells show prominent 
exclusion of Chmp1a from the nucleus, where Bmi1 is seen (Figure 2.8a). On the other hand, 
confocal images of HEK293T cells, while still showing predominantly cytoplasmic localization, 
show some nuclear immunoreactivity as well (Figure 2.8b). Primary cultures of cerebellar 
granule cells also show predominant cytoplasmic localization, along with a speckled nuclear 
pattern (Figure 2.8c). Overexpression of HA-tagged Chmp1a in cultured granule cells shows 
abundant nuclear Chmp1a with a punctate expression pattern, confirming the speckled nuclear 
localization of native Chmp1a (Figure 2.8d), and consistent with earlier reports that Chmp1a can 
appear in the nucleus (Stauffer et al., 2001). However, even with overexpression, Chmp1a and 
Bmi1 do not prominently co-localize within the nucleus, also in agreement with previous data 
(Stauffer et al., 2001). 
Immunohistochemical studies of mouse developing cerebellum and cerebral cortex 
showed widespread expression of Chmp1a in dividing and postmitotic cells. Chmp1a 
immunoreactivity was robust in the cytoplasm of EGL cells and Purkinje cells and slightly lower 
in the cytoplasm of IGL cells at P2 (Figure 2.8e,f), and confocal images again suggest low levels 
of speckled immunoreactivity in the nuclei of these cells (Figure 2.8e, f). At later stages of 
cerebellar development (P4, P10 and P29), Chmp1a expression persisted in Purkinje cells and 
granular cells, but at lower levels compared to P2 (Figure 2.9). E14.5 cerebral cortex showed 
Chmp1a expression in the neuroepithelial cells, with highest expression near the ventricular 
surface (Figure 2.8g). A similar pattern was seen in E12.5 cerebral cortex (Figure 2.9). At 
E17.5, the expression at the ventricular surface decreased, but expression was noted in 
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postmitotic neurons (Figure 2.9). At P2, expression in postmitotic neurons of the cortical plate 
decreased before increasing again at P10 (Figure 2.9). These expression studies confirm that 
Bmi1 and Chmp1a are often expressed in the same cells. On the other hand, the absence of 
widespread subcellular co-localization of Bmi1 and Chmp1a suggests that the regulation of Bmi1 
by Chmp1a is perhaps not mediated by direct physical interaction.
Our data suggest that CHMP1A is an essential CNS regulator of BMI1, which in turn is a 
key regulator of stem cell self-renewal. Chmp1a’s dual cytoplasmic and nuclear localization, and 
its connection to the ESCRT-III complex, position Chmp1a as a potentially crucial link between 
cytoplasmic signals and the global regulation of stem cells via the Polycomb complex.
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Figure 2.8
Chmp1a and Bmi1 expression in cultured cells and the developing mouse brain.
(a) Immunohistochemistry of NIH 3T3 cells shows cytoplasmic Chmp1a staining with exclusion 
from the nucleus, where Bmi1 is present. (b) Immunohistochemistry of HEK293T cells also 
shows cytoplasmic Chmp1a staining, with some nuclear immunoreactivity. (c) In dissociated 
cerebellar granule cells (Cb GC), endogenous Chmp1a localizes mostly to the cytoplasm, but 
also has a speckled nuclear localization. (d) When dissociated cerebellar granule cells are 
transfected with an HA-tagged Chmp1a overexpression construct (Cb GC OX), HA-Chmp1a is 
expressed robustly in the nucleus with prominent nuclear puncta (arrowheads). (e) In the 
developing cerebellum at postnatal day 2 (P2 Cb), Chmp1a is expressed primarily in the 
cytoplasm of cells in the external germinal layer (EGL), Purkinje cells (PC) and internal granule 
layer (IGL), with low level of speckled staining in the nucleus. (f) In P2 cerebellum, Bmi1 is 
expressed in the EGL and IGL cells that are positive for Chmp1a, and it primarily localizes to the 
nucleus. (g) In the developing cortex at E14.5, Chmp1a is expressed in both ventricular zone 
progenitors and cortical plate cells. Bmi1 is expressed in the same population of cells and at a 
level slightly lower than in the P2 cerebellum. LV = lateral ventricle. Scale bars = 20µm (a-g).
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Figure 2.9
Expression of Chmp1a in the developing mouse cerebellum and cerebral cortex.
At P4 and P10, Chmp1a was expressed in the cytoplasm of external germinal layer cells, 
Purkinje cells, and internal granule layer cells, but at a slightly lower level than at P2 (Figure 
2.8).  At P29, Chmp1a expression remained in the molecular layer, Purkinje cells and granular 
layer cells.  Like at P2, only faint nuclear Chmp1a staining was observed at these stages.  In 
E12.5 cerebral cortex, Chmp1a showed ubiquitous cytoplasmic expression in the neuroepithelial 
cells, with highest expression in the ventricular surface.  At E17, the expression at the ventricular 
surface decreased, but cytoplasmic expression was noted in postmitotic neurons.  At P2 and P6, 
expression in postmitotic neurons of the cortical plate decreased before increasing again at P8 
and P10. EGL= external germinal layer, PC = Purkinje cell layer, IGL = internal granule layer, 
ML = molecular layer, vz = ventricular zone, cp = cortical plate. Scale bars = 20µm.
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Supplemental Note 1
There are three affected individuals in Family 1 (CH3101, CH3102, and CH3105). 
CH3101 (female) was born at 33 weeks of gestation via Caesarean section.  The pregnancy was 
complicated by hyperemesis gravidarum.  At birth, her head circumference was 33cm (91st 
percentile), and weight was 2.2kg (57th percentile).  She was found to have ventricular septal 
defect during the neonatal period, which later resolved.  Her early motor and speech 
development were delayed.  She started to walk independently at 8 years of age.  She had 
bilateral equinocavovarus and claw foot deformities, which were worse on the left, and 
underwent orthopedic procedures for them.  On examination at 16 years of age, her head 
circumference was 50cm (-4.0 SD), height was 138cm (-3.7 SD) and weight was 32kg (-3.2 SD).  
No dysmorphic features were noted.  She spoke only in single words. She had poor social 
interaction.  There were no oral motor difficulties.  She had generalized hypotonia and walked 
with an ataxic gait.  She had normal deep tendon reflexes.  Her visual examination was 
remarkable for myopia, astigmatism and convergent strabismus.  She had negative TORCH titers 
and her karyotype was normal.  She underwent MRI of the brain at 12 years of age, which was 
remarkable for a very small cerebellar vermis and hemispheres.  Brain stem was thin with a short 
pons and long medulla.  There was no malformation of the cerebral cortex, but the cerebral white 
matter was moderately reduced in volume.  The corpus callosum was fully formed, but thin.  
Myelination of the white matter was age-appropriate. 
CH3102 (male), younger brother of CH3101, was born after an unremarkable pregnancy 
via Caesarean section at 38 weeks of gestation.  At birth, his head circumference was 36cm (86th 
percentile), and weight was 2.8kg (8th percentile).  He had delay in motor and speech 
50
development, and also had feeding difficulties.  He started to walk independently at 7 years of 
age.  He had surgery for bilateral talipes valgus.  On examination at 11 years of age, his head 
circumference was 50cm (-2.4 SD), height was 127cm (-2.4 SD), and weight was 26kg (-2.0 
SD).  No dysmorphic features were noted. He spoke only in single words, and had poor social 
interaction.  He had low muscle tone, except in the lower extremities, which were hypertonic and 
showed dystonic posturing.  He also showed involuntary, repetitive vertical head movements.  
He had increased deep tendon reflexes.  Ophthalmologic examination was remarkable for 
myopia, astigmatism, convergent strabismus of the right eye, bilateral pseudoptosis, and 
limitation of extraocular movements.  He had normal TORCH titers and normal karyotype.  He 
had MRI of the brain initially at 2 years and 5 months of age.  The findings were similar to that 
of his older sister (CH3101) including severe hypoplasia of the cerebellar vermis, cerebellar 
hemispheres, and pons.  There was no malformation of the cerebral cortex, and the cerebral 
white matter was moderately diminished in volume, with a fully formed but thin corpus 
callosum.  He had a repeat brain MRI at 12 years of age, and there was no change in these 
findings, suggesting that the condition is a developmental, rather than degenerative condition. 
CH3105 (male) is a cousin of CH3101 and CH3102, and was born after 38 weeks of 
gestation via Caesarean section with a birth head circumference of 36cm (86th percentile) and 
weight of 2.97kg (17th percentile).  There were no perinatal complications.  He had delay in 
motor and speech development, but no feeding difficulties.  He has not achieved independent 
walking yet.  On examination at 7 years of age, his head circumference was 50cm (7th 
percentile), height was 115cm (10th percentile), and weight was 27kg (79th percentile).  No 
dysmorphic features were noted.  He spoke only in single words, and had poor social interaction, 
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similar to his affected cousins.  He had esotropia.  He had low muscle tone, and showed 
involuntary, repetitive vertical movement of his head, similar to CH3102. He had normal deep 
tendon reflexes.  He had negative TORCH titers, Fragile X syndrome DNA testing, and ataxia 
gene sequencing panel.  He had normal plasma amino acid, very long-chain fatty acid, and urine 
organic acid profiles.  Serum transferrin electrophoresis was also normal.  He underwent MRI of 
the brain at the age of 3 months.  The findings were very similar to that of CH3101 and CH3102, 
and included a very small cerebellar vermis and hemispheres, a small pons, normal cerebral 
cortex, mild to moderate decrease in the cerebral white matter volume and a thin, but fully 
formed corpus callosum.  Myelination of the cerebral white matter was thought to be slightly 
delayed for his age.  None of the siblings in Family 1 has history of seizure. 
There are two affected children in Family 2 (CH2401 and CH2402).  CH2401 (female) 
was born after uncomplicated pregnancy at 36 weeks of gestation via Caesarean section due to 
breech presentation.  Measurements at birth are not available.  Joint stiffness was noted soon 
after birth, worse in the legs with hip dislocation.  She had gastrointestinal issues including 
constipation and gastroesophageal reflux.  Her development was severely delayed from early on, 
and she was found to have impaired ability to control swallowing.  Examination at 2 years and 7 
months of age revealed head circumference of 44cm (-2.8 SD), length of 82.5cm (-2.4 SD) and 
weight of 11.25kg (7th percentile).  She was found to have frequent babbling, but no 
communication with words or signs.  She did not interact with her environment, and did not 
follow commands.  She had mildly increased tone in the arms and moderately increased tone in 
the legs.  She showed frequent involuntary movements including side-to-side head shaking and 
slow kicking movements of the legs.  Ophthalmological examination at 2 years and 10 months of 
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age revealed no visual tracking.  Her eye movements and pupils were normal with no nystagmus. 
She had esotropia, hyperopia and astigmatism.  She was felt to have predominantly cortical 
visual impairment.  On examination at 5 years of age, her head circumference was 44.8cm (-4.0 
SD), length was 97cm (-2.3 SD), and weight was 14.5kg (4th percentile).  She had a mild 
scoliosis.  She did not show visual tracking, but responded to visual threat by blinking.  Side-to-
side head shaking was again noted.  She was diffusely spastic, with brisk deep tendon reflexes.  
She had normal serum lactate and pyruvate, serum amino acids and urine organic acids.  
Carbohydrate-deficient transferrin analysis and testing for MECP2 were also normal.  She had 
MRI of the brain twice, at 4 months of age and at 4 years of age.  They were remarkable for 
severe reduction in size of the cerebellum and pons, with a decreased cerebral white matter 
volume, a thin corpus callosum and grossly normal cerebral cortex.  There was no progression of 
the findings between the two studies. 
     CH2402 (female) is a younger sister of CH2401.  The course of the pregnancy was 
uncomplicated, but at 37 weeks of gestation, fetal decelerations were noted, and delivery was 
precipitous.  Her Apgar scores were 8 and 9, and her birth weight was 2.9 kg (38th percentile).  
She was noted to be microcephalic during the newborn period, and had a right club foot and 
multiple joint contractures, most prominent in the hands.  At 3 months of age, her head 
circumference was 37.4cm (-2.0 SD), length was 53cm (-2.6 SD), and weight was 6.4kg (89th 
percentile).  She was noted to have mild asymmetry of the forehead and hollow temples.  She 
had upturned nares, slightly tented upper lip, and mildly low set and posteriorly rotated ears.  She 
showed no visual tracking or social smile.  She had diminished spontaneous movements, but had 
frequent irregular small jerky movements, suggestive of chorea.  On examination at 11 months of 
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age, her head circumference was 41.8cm (-2.4 SD), length was 68.3cm (6th percentile), and 
weight was 9.95kg (72nd percentile).  She was noted to have brief visual tracking, but otherwise 
had gained few developmental milestones.  Choreiform movements involving all body regions 
were again noted.  She had diffusely increased muscle tone deep tendon reflexes.  She had a 
normal karyotype and negative urine culture for cytomegalovirus.  Echocardiogram was 
remarkable for patent foramen ovale.  Renal ultrasound was normal.  There was no history of 
seizure, and a video EEG monitoring showed no seizures or epileptiform activities.  She had 
MRI of the brain twice, at 2 days of age and 10 months of age.  They showed similar findings to 
her older sister (CH2401), including very small cerebellar vermis and hemispheres, small pons, 
no cortical malformations, severely reduced cerebral white matter with a fully formed but thin 
corpus callosum.  Her MRI also revealed abnormal T2 hyperintensity diffusely in the cerebral 
white matter, in addition to reduced volume.  There was no clear evidence of progression 
between the two studies. 
CH2701 (female) was born after a full term, uncomplicated pregnancy.  She reportedly 
did not cry at birth and had low Apgar scores.  At birth, her head circumference was 34.3cm (39th 
percentile) and weight was 3.3kg (42nd percentile).  She was noted to have arthrogryposis 
multiplex congenita.  At 3 weeks of age, her head circumference was 36cm (39th percentile), 
length was 48cm (3rd percentile), and weight was 3.4kg (17th percentile).  She had severe delay in 
her development. She never sat or stood independently.  She developed some babbling, but no 
meaningful words. She was noted to have mild swallowing incoordination and esophageal 
dysmotility.  At around 1 year of age, she started to have episodes of upward gaze deviation with 
head extension for a few seconds.  She also developed episodes of clonic head movements to the 
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left.  These episodes were felt to be seizures and she was placed on an anticonvulsant 
medication.  She began to have vomiting with eating and started to lose weight after 1 year of 
age, requiring G-tube placement and Nissen fundoplication.  She started to show developmental 
regression at around 18 months of age.  On examination at 2 years 8 months of age, she was 
noted to be cachectic with severe wasting.  Her head circumference was 41.5cm (-4.4 SD), 
length was 64cm (-7.4 SD), and weight was 5.3kg (-6.3 SD).  She was noted to have long 
eyelashes, bushy eyebrows and synophrys.  She had generalized hypertrichosis.  By 5 years of 
age, her nutritional status significantly improved, and she started to show slow progress in her 
development again.  On examination at 7 years of age, her head circumference was 48.0cm (-2.8 
SD), length was 86.1cm (-6.8 SD), and weight was 13.0kg (-3.6 SD).  She did not show visual 
fixation or tracking, but blinked to light.  Her eyes intermittently showed conjugate upward 
deviation for a few seconds.  She had low muscle tone on the trunk and increased tone on the hip 
and lower extremities.  She was noted to have multiple joint contractures of the lower 
extremities.  She was unable to roll over or sit independently.  She was able to reach for objects.  
Her ophthalmological examination was remarkable for no measurable vision, but normal ocular 
structures and no cataracts.  She had a normal karyotype and chromosomal microarray.  Plasma 
amino acid and urine organic acid analyses did not show a recognizable pattern for a disorder of 
amino acid or organic acid metabolism.  Complete blood count, serum immunoglobulin profile 
and T- and B-cell subsets were unremarkable.  Work-up for congenital disorders of glycosylation 
included carbohydrate-deficient transferrin analysis, as well as phosphomannomutase and 
phosphomannoisomerase activity on skin fibroblast, which were all unremarkable.  She had an 
MRI of the brain at 22 months of age.  She had a markedly hypoplastic cerebellar vermis and 
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hemispheres and brainstem, especially pons.  There was no malformation of the cerebral cortex, 
but the volume of the cerebral white matter was markedly diminished, with a very thin corpus 
callosum.  She had a follow-up MRI of the brain at 7 years of age, and the findings were 
unchanged, compared to the prior study, except for slightly more prominent subarachnoid spaces 
in the anterior middle cranial fossa.  Overall there was no clear evidence of progression of the 
previously noted findings.
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Supplemental Note 2
Though another isoform has been annotated for the human CHMP1A locus on the UCSC 
Human Genome Browser, the evidence in support of this alternative isoform is weak, and it is 
not detectable in any other species.  The putative alternative isoform (NM_001083314.1) is 
identical to CHMP1A, except it lacks exon 2.  Exon 2 is 20 nucleotides in length, therefore the 
majority of the alternative isoform is in a different reading frame from CHMP1A.  The 
alternative isoform is predicted to encode a protein of 240 amino acids.  The mutation identified 
in Families 2 and 3 is predicted to result in a conservative missense change in this alternative 
isoform (p.A24V), whereas the mutation identified in Family 1 creates a frameshift and 
premature stop codon for both isoforms.  While western blot analysis shows complete absence of 
CHMP1A in affected individuals from both families, similar western blot analysis using an 
antiserum against the predicted alternative isoform shows low or undetectable expression of the 
alternative isoform in both affected and unaffected individuals from Family 2 (CH2401) (data)not)shown).  In mouse, only the transcript orthologous to CHMP1A has been annotated, and it 
has 97% amino acid identity to human CHMP1A.  When exon 2 was removed from the mouse 
Chmp1a sequence, the resulting amino acid sequence would be dissimilar to the human 
alternative isoform, and only 21 amino acids in length.  In the chimpanzee genome, the 
CHMP1A ortholog has not been annotated, but N-SCAN gene prediction software (Gross et al., 
2006; Korf et al., 2001) predicts the presence of a CHMP1A homolog, with 95% amino acid 
identity to human CHMP1A.  Again, removing exon 2 results in a highly dissimilar amino acid 
sequence from the human alternative isoform, with the resulting protein length being only 28 
amino acids.  Furthermore, the NHLBI Exome Sequencing Project Exome Variant Server lists 5 
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nonsense variants for the alternative isoform, but none for CHMP1A.  Taken together, these 
findings strongly suggest that CHMP1A is the essential form. 
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Methods
URLs
UCSC Human Genome Browser: http://genome.ucsc.edu/
Primer3: http://frodo.wi.mit.edu/primer3/
NetGene2: http://www.cbs.dtu.dk/services/NetGene2/
dbSNP: http://www.ncbi.nlm.nih.gov/projects/SNP/
1000 Genomes Project: http://www.1000genomes.org/
NHLBI Exome Sequencing Project: http://evs.gs.washington.edu/EVS/
Genetic Screening
The genetic study was approved by Beth Israel Deaconess Medical Center and Children’s 
Hospital Boston Institutional Review Boards. Appropriate informed consent was obtained from 
all involved human subjects. 
The affected individuals and their parents from Family 1 and the affected individuals 
from Family 2 were subjected to genome-wide SNP screen with Affymetrix GeneChip Human 
Mapping 250K Sty Array, performed at the Microarray Core of the Dana Farber Cancer Institute. 
We carried out fine mapping using microsatellite markers identified using the UCSC Human 
Genome Browser (Kent et al., 2002), with synthesized fluorescent-labeled primers (Sigma-
Genosys). Two point and multipoint LOD scores were calculated using Allegro (Gudbjartsson et 
al., 2000), assuming recessive inheritance with full penetrance and a disease allele frequency of 
0.001. Sequencing primers were designed using Primer3 (Rozen et al., 2000), and genomic 
DNA was sequenced using standard Sanger technology. Neurologically normal Caucasian 
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control DNA samples were obtained from the Coriell Cell Repositories (Coriell Institute for 
Medical Research). All nucleotide numbers are in reference to CHMP1A isoform 2 cDNA 
(NM_002768, in which A of the ATG start site is +1) from the UCSC Genome Browser.
Analysis of CHMP1A splicing
Splice prediction software NetGene2 (Brunak et al., 1991) was used to determine the 
effect of the Family 1 allele on CHMP1A splicing. EBV-transformed lymphocytes were grown in 
RPMI-1640 with 15% (v/v) fetal bovine serum and 1% (v/v) penicillin/streptomycin in a 
humidified incubator at 37oC in 5% CO2. RNA was isolated using the RNeasy Mini Kit 
(Qiagen). Total RNA (5µg) was used for first-strand synthesis with oligo(dT) primers and the 
SuperScript III First-Strand Synthesis SuperMix (Invitrogen), and 1µl of the product was used 
for the subsequent PCR reaction, with primers from exon 1 to exon 5 of CHMP1A 
(NM_002768).
Proliferation assay of lymphoblastoid cell lines
EBV-transformed lymphoblastoid cell lines from eight control subjects and two patients 
(CH2401 and CH3101) were grown as described above. From each cell line, 20 million cells 
were grown, and then one million cells were aliquoted into four sets of five T25 flasks filled with 
10ml of media. Each set was allowed to grow for 24, 48, 72, and 96 hours, respectively. Cell 
densities were estimated using a hemocytometer.
Quantitative PCR
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EBV-transformed lymphoblastoid cell lines were grown and cDNA was generated as 
described above. INK4A and ARF levels were quantified using the StepOnePlus Real-Time PCR 
System (Applied Biosystems), with GAPDH as a control. Primer sequences used are as follows: 
INK4A (5’-CCCCTTGCCTGGAAAGATAC and 5’-AGCCCCTCCTCTTTCTTCC), ARF (5’- 
AACATGGTGCGCAGGTTC and 5’- GGGATGTGAACCACGAAAAC), and GAPDH (5’- 
CCAAGGTCATCCATGACAAC and 5’-GGCCATCCACAGTCTTCTG).  
Chromatin Immunoprecipitation
EBV-transformed lymphoblastoid cells were counted and 100 million cells were fixed in 
1% paraformaldehyde in PBS for ten minutes at room temperature, followed by a quenching step 
for 10 minutes at room temp with 30mM glycine. Cells were then washed twice with ice-cold 
PBS and flash frozen with liquid nitrogen. Cells were later thawed on ice, and serially washed 
for 10 minutes, pelleted at 3000 rpm for 10 minutes, and resuspended in three buffers (10mL 
Buffer 1: 50mM HEPES KOH pH 7.5, 140mM NaCl, 1.0mM EDTA pH 8.0, 10% glycerol, 0.5% 
NP-40, 0.25% Triton X-100; 10mL Buffer 2: 200mM NaCl, 1.0mM EDTA pH 8.0, 0.5mM 
EGTA pH 8.0, 10mM Tris pH 8.0; 2mL Buffer 3: 10mM Tris pH 8.0, 1.0mM EDTA pH 8.0, 
0.5mM EGTA pH 8.0). All three buffers were supplemented with protease inhibitor cocktail 
(Roche). The Buffer 3-contained cell lysates were sonicated (Misonix 3000) for sixteen cycles of 
15 seconds ON and 2 minutes OFF at power setting 7.5, or until the DNA fragmentation was 
such that the vast majority of fragments were between 200-500bp. The equivalent volume 
corresponding to 20 million cells were precleared for 2 hrs with 20µL of pre-washed protein A/G 
plus sepharose beads (Santa Cruz Biotechnology, sc-2003), and spun for 1 minute at 6000 rpm. 
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5% of the supernatant was saved as the input DNA for each sample. Then 4µg of the BMI1 
antibody (Abcam, ab14389) was applied to the remaining supernatant overnight at 4oC, on a 
rocking platform. The next day, 20µL of beads were incubated with the sample at 4 oC for 2 hrs, 
spun for 1 minute at 6000 rpm, the supernatant saved, and the beads washed 2x5 min in each of 
three serial salt washes (Wash Buffer 1 [Low Salt]: 0.1% SDS, 1.0% Triton X-100, 2mM EDTA, 
20mM Tris-HCl pH 8.1, 150mM NaCl; Wash Buffer 2 [High Salt]: 0.1% SDS, 1.0% Triton 
X-100, 2mM EDTA, 20mM Tris-HCl pH 8.1, 500mM NaCl; Wash Buffer 3 [LiCl]: 250mM 
LiCl, 1.0% NP-40, 1.0% deoxycholic acid, 1.0mM EDTA, 10mM Tris pH 8.1). The beads were 
washed once more in TE Buffer, and then eluted with 100uL of elution buffer (10mM Tris pH 
8.0, 1.0mM EDTA pH 8.0, 1% SDS) for 10 minutes at 65oC. The beads were spun at 6000 rpm 
for 1 minute, and a second elution was performed and combined with the first. The 200µL eluate 
was transferred to a new tube, and reverse crosslinked at 65oC overnight (12-16 hours). The next 
day, 10ug of RNAse A (New England Biolabs) was added for 2 hours at 37oC, followed by 
100µg of proteinase K (New England Biolabs) for 2 hours at 37oC. DNA was extracted from the 
samples via phenol-chloroform extraction and column purification (Qiagen Qiaquick), and eluted 
with 2x50µL of EB Buffer. qPCR primers were assessed for specificity by their melt curves on 
the StepOnePlus (Applied Biosystems), and a standard curve was determined using four ten-fold 
serial dilutions for each primer using the input DNA samples. Fold-enrichments for each ChIP 
sample were normalized to input Ct. Primer sequences used are as follows: INK4A promoter (5’-
CCAATTCCCCTGCAAACTTC and 5’-CAACGCACCGAATAGTTACG), ARF promoter (5’-
ACATCACCGATCCTTTCTGG and 5’-TCCTTGCCCTGCTTTTACTG), 10 kb upstream (5’-
AGGTTTTAGCCAAGGGGATG and 5’-ATGTTGTTGGGGCTACTTCC).
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Zebrafish morpholino experiments
ATG-targeting morpholinos were designed against chmp1a (5’-
CAGTGTGTCGTCCATGTCGCTGTCT), bmi1-a (5’-
GCATCGTCATGGGATAGAAAAGAAC), bmi1-b (5’-
CATTGTCATGGGAGTACGCCGACCT), and the INK4A zebrafish ortholog (ink4a; 5’-
TAAAGCGCGTCTAAACCTACCTGTA) (GeneTools). In all experiments where bmi1 
morpholinos were used, bmi1-a and bmi1-b were injected together. Injections were performed at 
the one-cell stage. Optimal doses for the chmp1a, bmi1a+b and ink4a morpholinos were 4.5ng, 
1.2ng, and 4.0ng, respectively. At 28 hours post fertilization (hpf), the embryos were visualized 
using a stereo microscope (Zeiss). A second ATG-targeting chmp1a morpholino was designed 
(5’-TCGGGTTATTCGCTGCTCTTCTGCT), and 3.0ng was injected at the one-cell stage, to 
check for phenocopying of the other chmp1a morpholino.
For the rescue experiment, morphants were screened at 28hpf and scored for the presence 
of a defect in the angle of the head to the tail (measured at the otic vesicle) or a deviation in the 
straightness of the tail (Kimmel et al., 1995). Human CHMP1A cDNA was PCR amplified from 
control human lymphoblastoid cell total RNA, using primers 5’-
CCGGAAGTGGGGCGGCGACCCCG and 5’-TGTTTATTTACAACAGCATTCTA. The PCR 
product was subcloned into the pCS2+ vector, and 5’ capped mRNA was synthesized in vitro 
using the mMESSAGE kit (Ambion). mRNA was diluted in 0.1M KCl, and titrated for the 
rescue experiments.
63
For the histological preparation, morphants were grown at 28oC for 5 days, fixed 
overnight at 4oC in paraformaldehyde (PFA), then embedded in 3% low-melt agarose blocks (in 
phosphate buffered saline), which were fixed again in 4% PFA/PBS overnight. The fixed agarose 
blocks were embedded in paraffin and sectioned at 5µm thickness in the sagittal plane. Sections 
were stained by standard techniques with hematoxylin and eosin, and visualized using a 
brightfield microscope (Nikon).
Immunocytochemistry and immunohistochemistry
NIH 3T3 and HEK293T cells were grown in DMEM with 10% (v/v) fetal bovine serum 
and 1% (v/v) penicillin/streptomycin, fixed and stained with antibodies against Chmp1a (1:200; 
Abcam, ab36679) and Bmi1 (1:250; Abcam, ab14389) using standard techniques, and visualized 
on a confocal microscope (Nikon). 
All animal work was approved by Harvard Medical School, Beth Israel Deaconess 
Medical School and Children’s Hospital Boston Institutional Animal Care and Use Committees.
Cerebellar granule neuron cultures were prepared as described (Bilimoria et al., 2008). 
Briefly, cerebella were dissected from euthanized postnatal day 5 mouse pups, meninges 
removed, and placed in ice cold HHGN (HBSS, 2.5mM HEPES, 35mM glucose, 4mM sodium 
bicarbonate, filter sterilized). The cerebella were washed with HHGN four times, then digested 
lightly with trypsin/DNase solution (5mL HHGN, 500µg DNase, 50mg trypsin), for 20 minutes 
at room temperature. The trypsin/DNase solution was removed and the cells were washed 3x 
with HHGN, then triturated in 8mL Basal Medium Eagle (with 800µg DNase) using a P1000 
pipette until all clumps were dissociated. Cells were pelleted at 800rpm for 5min, and 
64
resuspended slowly in 5mL plating medium (25mM KCl, 10% Hyclone bovine growth serum, in 
Basal Medium Eagle with 1% L-glutamine, 1% penicillin/streptomycin, filter sterilized). 
Coverslips coated the previous night at 4˚C with poly-L ornithine were washed 3 times with 
sterile water. Cell density was measured using a hemocytometer, and one million cells were 
plated on each coverslip with 500µL plating media, in a 24-well plate. After one day in vitro 
(DIV) in a 37˚C incubator, 20µL of 250µM AraC (cytosine-1-β-D-arabinofuranoside) was added 
to each well to arrest mitosis of non-neurons. At 2 DIV, the conditioned media was collected 
from each well, and the wells were washed with DMEM. The cells were then transfected with 
the HA-Chmp1a mammalian expression construct (EX-Mm15805-M06, GeneCopoeia). 
Transfection solution (87.6uL HBSS, 4.4µL of 2.5M calcium chloride, with 1.5µg of plasmid 
DNA) was prepared at room temperature, and 35µL of the transfection solution was added to a 
total of 400µL of conditioned media to each well. After 36 additional hours (4 DIV), cells were 
fixed with 4% paraformaldehyde for 20 minutes at room temperature, washed with PBS, and 
stained with antibodies against HA (1:100; Abcam, ab9110) and Bmi1 (1:250; Abcam, ab14389). 
Untransfected cells were processed similarly and stained with antibodies against Chmp1a (1:200; 
Abcam, ab36679) and Bmi1. 
Tissues were perfused with 4% paraformaldehyde (PFA), dissected and fixed overnight in 
4% PFA, then embedded in paraffin for sectioning. After rehydration of the slides in serial 
washes with xylene, 50% xylene/ethanol, 100%/70%/50%/30% ethanol, and finally PBS, the 
slides were boiled in antigen retrieval solution (R&D Systems) for 20 minutes. Slides were 
treated with PBST (PBS with 0.1% Tween-20) supplemented with 5% goat or donkey serum for 
1 hour, followed by addition of antibodies against Bmi1 (1:100; Millipore, clone F6) or Chmp1a 
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(1:250; Abcam, ab36679 and ab104103) for overnight incubation at 4˚C. Slides were washed 3x5 
minutes in PBST, then developed with secondary antibodies conjugated to Alexa Fluor dyes 
(Invitrogen) for 2 hours at room temperature. Slides were again washed 3x5 minutes in PBST, 
then mounted with Fluoromount-G (SouthernBiotech), and visualized on a confocal microscope.
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Chapter 3:
CHMP1A is implicated in neural progenitor proliferation through Wnt and Shh 
signaling pathways
70
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Introduction
 Charged multivesicular body protein/Chromatin modifying protein 1A (CHMP1A) is a 
member of the ESCRT-III endosomal sorting complex, but is also suggested to localize to the 
nuclear matrix and regulate chromatin. In the previous Chapter, we demonstrated how CHMP1A 
could play a role in regulating the chromatin-modifying effects of BMI1 on INK4A. Here we 
seek to explore alternative pathways implicated by Chmp1a loss-of-function. The endosomal 
sorting role of CHMP1A on the disease pathogenesis of pontocerebellar hypoplasia is not 
mutually exclusive from its role in regulating chromatin structure. Since the initial discovery of 
the ESCRT pathway, component proteins have been found play a crucial role in the formation of 
vesicles that bud away from the cytoplasm, trafficking ubiquitinated cargo to the lysosome for 
degradation (Hurley and Emr, 2006), or to the nucleus (Lutz et al., 2012). ESCRT-III proteins 
form a lattice on the endosomal membrane via N-terminal interactions, while their C-terminal 
domains act to recruit regulatory proteins that are required for function (such as VPS4) 
(McDonald et al., 2009). 
 It has also recently been described that ESCRT proteins also have a role in membrane 
abscission in the final stages of cell division, in a biophysical process not unlike its role in 
budding vesicles off from the plasma membrane (Wollert et al., 2009). Cytokinesis requires 
ESCRT-III in archaea, where ESCRT-III and VPS4 are also sufficient for membrane abscission, 
but it is not known if it is an absolute requirement in mammalian neurodevelopment (Lindas et 
al., 2008). 
 We sought to test if loss-of-function of Chmp1a in mouse has direct effects on neural 
development. Since ESCRT-III is involved in trafficking of membrane-bound components to the 
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lysosome and nucleus, it appears ideally positioned to regulate critical signal transduction steps 
involved in neural progenitor proliferation. Notably, Wnt and Shh pathways require the 
transduction of a ligand-bound membrane receptor interaction, culminating in translocation of a 
protein to the nucleus to affect transcription (beta-catenin in the case of canonical Wnt signaling; 
Gli1-3 in the case of Shh signaling) (Kim et al., 2009). Disruption of ESCRT-III may manifest is 
dysregulation of these canonical signaling pathways required for normal brain development. 
Alternatively, if the effect of Chmp1a in brain development is mostly due to its biophysical role 
in membrane abscission, then disruption to Wnt or Shh pathways may not be apparent.
 We utilized a gene-trap line to assay for gross morphological deficits, as well as defects 
in cerebellar progenitor proliferation. In addition, we assayed for defects in Wnt- and Shh-
stimulated transcription in vitro using shRNA targeted against Chmp1a. Our results indicate early  
post-natal lethality of some Chmp1a null mice, a decrease in brain and body size, but were 
unable to expose significant effects on the proliferation of cortical or cerebellar progenitor cells. 
However, in vitro assays robustly show a defect in both Wnt- and Shh-pathways in the presence 
of Chmp1a knockdown. Altogether this suggests compelling future directions in elucidating the 
precise role and contribution of Chmp1a and ESCRT-III in a cytoplasmic regulation of Wnt and 
Shh through multivescular bodies, perhaps in non-complementary roles to its function in Bmi1-
mediated regulation of progenitor proliferation.
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Methods
Chmp1a gene-trap mice
 Cryopreserved sperm from a Chmp1a-targeting gene-trap line, B6;129P2-
Chmp1aGt(XC472)Byg/Mmucd, was ordered from Bay Genomics. The gene-trap vectors used within 
BayGenomics contain a splice-acceptor sequence upstream of a reporter gene, β-geo (a fusion of 
β-galactosidase and neomycin phosphotransferase II).  These vectors insert randomly into 
introns.  The resulting insertional mutation creates a fusion transcript containing sequences from 
exons upstream to the insertion joined to the β-geo marker. 
 IVF was performed at the Beth Israel Deaconness Medical Center animal facility, with 
the sperm introduced into a 129sv female. The crosses of the resulting offspring were genotyped 
using the following PCR primers:
5’-GAGACAGCGGGTCCGTAAC, 5’-AACACACACTCGAACCGAAAG, 5’-
GGTCCTAGTCGGAGGTCTCG
The gene-trap allele forms a 163bp band, whereas the wildtype band is 204bp. Mice 
heterozygous for the gene-trap allele will carry both bands.
Histology
 To generate histopathological sections, surviving mice were sacrificed at postnatal day 
20, perfused with PBS then 4% paraformaldehyde, organs carefully dissected out, then postfixed 
overnight in 4% paraformaldehyde. Tissues were embedded in paraffin blocks using standard 
techniques, then sectioned for H&E staining.
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Western blotting
 Postnatal day 20 mice were sacrificed, and organs harvested and flash frozen or 
homogenized using a pipet tip or syringe, in RIPA lysis buffer with protease and phosphatase 
inhibitors (Roche). Protein concentrations were measured using the BCA assay (Pierce), and 
western blot run using standard techniques in a 4-12% Bis-Tris Novex gel. Lysate from the 
spleens of homozygous genetrap, heterozygotes, and homozygous wildtype littermates were run 
and stained for levels of Chmp1a normalized to beta-actin. Antibodies used were chicken anti-
Chmp1a (Abcam ab14389, 1:2000) and monoclonal mouse anti-beta-actin (clone AC-15, Abcam, 
1:15,000).
BrdU pulse-chase in mouse cerebellum
 For BrdU labeling, P6 pups were injected intraperitoneally with 100 ug BrdU/g body 
weight. Pups were sacked one hour later for analysis of S-phase cells, their brains dissected, 
fixed in 4% paraformaldehyde overnight at 4-degrees C, and processed for paraffin sectioning. 
Deparaffinized and rehydrated sections were treated with 4 N HCl for 10 min to denature DNA, 
neutralized for 5 min with 0.1 M sodium borate buffer (pH 8.5), followed by the addition of 
primary antibody (mouse anti-BrdU, Sigma, clone #: BU-33, 1:250 dilution). Nuclei were 
counterstained with DAPI. BrdU+ cells per field were counted, and averaged for all the sections 
through an entire folia, then compared between gene-trap (or knockout), and heterozygous or 
wildtype littermate controls.
shRNA construct design and cloning
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 Chmp1a knockdown constructs in the HuSH plasmid backbone (Origene) were cloned 
and tested in 3T3 cells for knockdown of co-transfected N-terminal HA-tagged Chmp1a 
(Genecopoeia, EX-Mm15805-M06). Clone 228 was used in subsequent experiments.
 For the Shh luciferase assay, Chmp1a shRNA lentivirus constructs in the pLKO.2-puro 
backbone (Sigma) were cloned and tested against endogenous expression in 293T cells. Clone 
NM_145606.1-226s1c1 was used in subsequent experiments.
In utero electroporation
 In utero electroporation was performed as described previously (Saito et al., 2006). 
Briefly, uterine horns of anesthetized pregnant dams at E13.5 were exposed through an incision 
in the peritoneum. DNA (3–4 mg/ml) was injected manually through the uterine wall into the 
lateral ventricle using pulled micropipettes. Four pulses of 40–55 V (50 ms duration) were 
applied across the uterine wall using a BTX ECM830 pulse generator. The uterus was then 
replaced in the abdominal cavity and embryonic development allowed to proceed normally, until 
E17.5, when the mother was sacrificed and the embryos dissected, drop fixed in 4% PFA, and 
subsequently embedded in paraffin for sectioning. 
 
Wnt luciferase assay
 Wnt luciferase assays were performed as described previously (Mao et al., 2009). Briefly 
5x10^5 293T cells were seeded into 24-well plates and transfected with 0.8 µg of 
Super8XTOPFLASH or Super8XFOPFLASH (negative control) and 0.1 µg of pRL-TK using 
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Lipofectamine 2000 (Invitrogen). 24 hours after transfection, transfected cells were stimulated 
with Wnt3a-conditioned medium (Wnt3a CM) for 14 hours and TCF reporter activity was 
measured using the Dual-Luciferase Assay System (Promega). For the negative control 
experiments, 1.6 µg of β-catenin shRNA vector was transfected, or the Chmp1a shRNA plasmid 
cotransfected with 0.4 µg of at N-terminal beta-catenin binding site-deficient high mobility group 
(TCFdeltaN) construct using Lipofectamine 2000, and transfected cells were treated with Wnt3a 
(200 ng/ml). All firefly luciferase activities were normalized with Renilla luciferase activity.
Shh luciferase assay
 Shh luciferase assays were performed using viral infection of Shh Light II cells (ATCC). 
Shh Light II is an NIH/3T3-derived cell line in 1999 (Sasaki et al., 1997), a Zeocin-selectable 
stable cell line with GLI-responsive Firefly luciferase reporter, pSV-Neo, pRL-TK constituitive 
Renilla-luciferase expression vector, and pVgRXR vector. It is compatible with the Dual-
Luciferase reporter system (Promega). 50,000 cells were plated per 24-well plate along with 
pLKO-packaged lentiviruses carrying either scrambled control, target shRNA, LacZ-targeting 
shRNA (negative control), or Smo-targeting shRNA (negative control) plasmids. The cells were 
treated with puromycin selection after 24 hours, then treated the next day with Smoothened 
agonist (SAG) or vehicle control. After three days the cells were lysed and analyzed for renilla 
and firefly expression using a plate reader (Molecular Devices).
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Results
Chmp1a gene-trap mice surviving perinatal lethality show defects in brain and body size
 The vast majority of Chmp1a gt/gt mice did not survive the perinatal period between 
postnatal day zero (P0) and P8 (Figure 3.1a). Genotyping results at P20 of surviving mice 
demonstrate a substantial reduction in gt/gt homozygotes. At P0, 18% of pups are recovered and 
genotyped as gt/gt. In the P20 mice, protein levels of Chmp1a from spleen lysates show a 
doublet at the expected size (Figure 3.1b), and a faint level of Chmp1a expression in the gt/gt 
spleen, but far below wildtype levels. The brain and body size of the gt/gt mice are reduced 
compared to wildtype littermate controls, however the brain:body ratio is not substantially 
reduced (Figure 3.1c). Parasagittal sections of gt/gt mouse brain at P20 shows a modest decrease 
in overall brain size, perhaps slightly more of a decrease in cortical volume, but the cerebellum is 
not proportionally smaller (Figure 3.1d,e). No gross malformation or abnormality is apparent on 
histology. 
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Figure 3.1
Chmp1a gt/gt mice show perinatal lethality and reduced brain and body size.
(a) The fraction of recovered mouse pups by their genotype, at the corresponding litter age shows 
a decrease in gt/gt survival in the postnatal period. (b) Chmp1a lysate levels from +/+, +/gt, and 
gt/gt P20 mouse spleen shows a substantial but not complete reduction in gt/gt on Western blot. 
Parallel lanes were loaded using 20ug or 50ug of total lysate. Beta-actin (Actb) was used as a 
loading control. (c) Both brain and body mass of the Chmp1a gt/gt mouse at P20 is reduced 
compared to littermate controls, however the brain:body ratio is not substantially changed in gt/
gt. (d-e) H&E-stained sections of Chmp1a +/gt and Chmp1a gt/gt from comparable parasagittal 
planes shows a mild decrease in cortex and cerebellar size in the gt/gt mouse, without grossly 
apparent changes in morphology or cerebellar foliation.
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Figure 3.1 (Continued)
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Chmp1a gene-trap mice show no profound defect in cortical or cerebellar proliferation
 To more closely interrogate a possible subtle deficit on cerebellar granule cell 
proliferation in the Chmp1a gt/gt mice, we performed a BrdU pulse-chase experiment at P6. 
Compared to Bmi1-/- mice, which show a nearly 50% reduction in cells in S-phase in a given 
cerebellar field, Chmp1a gt/gt mice show a mild but not significant reduction (Figure 3.2a). 
Since the proportion of cells in S-phase is sensitive to the postnatal age, we repeated the 
experiment in another P6 litter, with similar results (Figure 3.2a). 
 To test for a role in cortical progenitor proliferation, we performed in utero 
electroporations in embryonic mice at E13.5, using shRNA constructs targeted against Chmp1a. 
GFP-positive transfected cells were counted in E17.5 brain sections (Figure 3.2b). The ratio of 
cells in the VZ/SVZ to the total number of cells in a radial column is a sensitive proxy for defects 
in the maintenance of cell proliferation and premature neuronal differentiation. In Chmp1a gt/gt 
embryos there is no significant change in the distribution of GFP-positive cells in the cortex 
compared to control (shRNA plasmid targeted against firefly luciferase) (Figure 3.2b).
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Figure 3.2
Chmp1a loss-of-function shows no significant difference in cerebellar granule cell or 
cortical progenitor proliferation.
(a) BrdU-positive cells per field were counted and average from sections of P6 cerebella from 
the Bmi1-/-, Bmi1+/- , Chmp1a +/gt, and Chmp1a gt/gt mice injected with intraperitoneal BrdU 
for 60 minutes. Bmi1-/- show a 50% reduction in cells in BrdU-positive cell fraction compared to 
heterozygous littermate controls, whereas a mild but not significant reduction is seen in Chmp1a 
gt/gt. (b) Representative images of E17.5 cortices from E13.5 electroporated embryos are shown 
on left. Quantification of GFP-positive cells is shown on the right. Dotted lines demarcate the 
boundary between the VZ/IZ and IZ/CP. LV = lateral ventricle, CP = cortical plate, VZ = 
ventricular zone, IZ = intermediate zone. pSil-Luci or Luci = pSilencer targeting firefly 
luciferase (positive control). pSil-shRNA-228 or 228 = pSilencer construct targeting Chmp1a. 
Error bars = S.E.M.
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Figure 3.2 (Continued)
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In vitro assays of Chmp1a knockdown show defects in Wnt- and Shh-pathway signal 
transduction
 Given the possibility that small but detectable levels of protein in the Chmp1a gt/gt mice 
could be compensating for a true null phenotype, we explored in vitro approaches to probe the 
effects of Chmp1a knockdown. To assay for a role in Shh-stimulated signal transduction, we 
infected Shh Light II cells (ATCC) with lentivirus targeted against Chmp1a, and compared the 
effects on Gli1-luciferase transcription to negative controls (lentivirus containing scrambled 
shRNA, or targeted against LacZ) and a positive control (lentivirus targeted against Smo). 
Results of the stimulation with a Smoothened agonist (SAG, Millipore) were compared to 
unstimulated trials using vehicle. Chmp1a knockdown substantially decreased SAG-stimulated 
Gli1 transcription, with nearly 50% reduction in activity compared to an untargeted lentivirus 
(Figure 3.3a).
 To discern the role of Chmp1a in regulating the Wnt pathway, we measured Wnt-
activated transcription in the presence of reduced Chmp1a levels. We transfected 293T cells with 
our control or shRNA knockdown construct and a luciferase reporter construct containing eight 
copies of the TCF/LEF-binding site (8XSuperTOPFLASH), which can be bound and activated 
by a core component of the Wnt signaling pathway, beta-catenin (Molenaar et al. 1996). We 
confirmed that shChmp1a expression resulted in a significant decrease in Wnt- mediated 
luciferase reporter activation compared with controls (Figure 3.3b). This effect was titratable 
depending on the dose of shRNA (between 1.0 and 50ng of plasmid per well) (Figure 3.3b). 
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Figure 3.3
Chmp1a shRNA decreases both Wnt-activated and Shh-activated transcription.
(a) Shh Light II stable cell lines containing Gli1-luciferase and dual-luciferase reporter constructs 
show a substantial decrease in Smoothened agonist (SAG) stimulated Gli1-luciferase 
transcription in the presence of Chmp1a shRNA lentivirus (shChmp1a) compared to lentivirus 
with a scrambled shRNA. The extent of induction of the pathway with no virus is shown at left. 
shLacZ is a negative control lentivirus containing shRNA targeting LacZ. shSmo is a positive 
control lentivirus containing shRNA against endogenous Smoothened. Similarly panel (b) shows 
the dual-luciferase reporter assay in 293T cells using Wnt3a conditioned medium (Wnt CM) to 
measure TCF/LEF-luciferase activity. Normalized to the induction seen with Wnt CM in the 
scrambled control, transfection with shRNA targeting Chmp1a shows a titratable decrease in 
Wnt-induced transcription (shChmp1a01 = 1.0ng HuSH plasmid (Origene) per well; 
shChmp1a50 = 50ng). shBcat = shRNA targeting beta-catenin, shChmp1a50+TCFdeltaN = 
cotransfection of shRNA targeting Chmp1a with an uninducible TCF/LEF-luciferase construct.
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Figure 3.3 (Continued)
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Discussion
 While the surviving homozygous gene-trap Chmp1a mice described here have reduced 
brain and body size, the degree of cerebellar and cortical volume reduction is not as remarkable 
as seen in human patients with loss-of-function mutations to CHMP1A (Chapter 2), or as severe 
as in the Bmi1-/- mouse. Several explanations could reconcile this difference. First, the Chmp1a 
gene-trap mouse is derived from a mixed background of B6, 129P2, and 129sv, while the Bmi1 
mouse is in a pure background of C57Bl6. Inbred mouse strains vary widely in their behavior 
and brain size (Wahlsten et al., 2006; Sandberg et al., 2000; Inouye et al., 1980). Backcrossing 
the Chmp1a-gt line to a C57Bl6 background (ongoing), is one approach to resolving possible 
confounding strain-specific effects. Second, there is evidence of faint expression of normal-sized 
Chmp1a in the gt/gt spleen (Figure 3.1b), suggesting the possibility of some transcript escaping 
the En2 splice acceptor of the gene-trap. The overall levels are less than 1% of endogenous, 
however small amounts of Chmp1a could be sufficient to rescue any severe phenotype. Of note, 
the only human disease alleles identified to-date are complete loss-of-function; it is possible that 
hypomorphic alleles do not manifest with disease pathology. Third, the mice analyzed for 
histology and proliferative defects, by definition, survived the postnatal period where the 
lethality of the gt/gt haplotype appears most severe (Figure 3.1a). Other alleles on modifier 
genes could explain why the gt/gt mice that survive to P20 appear “rescued”. Future work on 
characterizing the gt/gt mice at P0 could expose a more severe defect in an animal that would not 
survive the postnatal period. One human patient with homozygous CHMP1A mutations, 
CH2701, had severe feeding difficulty after birth with failure-to-thrive, and would not have 
survived if a percutaneous endoscopic gastronomy (PEG) tube was not placed. It is possible that 
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the Chmp1a gt/gt mice also have difficulty with peristalsis or feeding, and as a result are 
cannibalized by the mother.
 The subsequent inability to demonstrate a defect in BrdU-incorporation in P6 pups 
(Figure 3.2a), or a defect in cortical progenitor proliferation or migration (Figure 3.2b), could 
be secondary to the reasons outlined above. In addition, the degree of microcephaly in the human 
CHMP1A patients suggests a mild deficit. In utero electroporation may not be sensitive enough 
to expose an analogously mild phenotype in the mouse. On the other hand, Bmi1 shRNA 
electroporation at E13.5 showed a severe defect, disrupting nearly half of all cortical progenitors, 
out of proportion to the degree of microcephaly expected from the Bmi1 knockout studies 
(Fasano et al., 2007; Zencak et al., 2005; Jacobs et al., 1999). 
 By contrast to the mild effects seen in the Chmp1a gt/gt mouse and Chmp1a in utero 
RNAi, knockdown of Chmp1a in vitro shows pronounced dampening of both Wnt- and Shh-
stimulated transcriptional activity (Figure 3.3). Recent compelling evidence suggests that 
multivesicular bodies (MVBs) are critical for glycogen synthase kinase 3 (GSK3) sequestration, 
and that GSK3 is a “master regulator” of Wnt, Shh, and other signaling pathways to maintain 
neural progenitor proliferation (Taelman et al., 2010; Kim et al., 2009). The biochemical details 
of this model have been worked out in more detail with respect to Wnt signaling, whereby 
MVBs (through ESCRT-mediated processes) sequester Wnt-bound receptor complexes (of which 
GSK3 is member) inside endosomes, thereby preventing GSK3 from degrading beta-catenin. 
Accumulating beta-catenin effectively serves to maintain progenitor proliferation. Therefore 
defects in MVB sequestration of GSK3 would be predicted to lead to decreased levels of 
cytosolic beta-catenin, and decreased TCF/LEF transcription. Our data on decreased Wnt-
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stimulated TCF/LEF-luciferase activity in the presence of Chmp1a shRNA, is consistent with 
this model (Figure 3.3b).
 Defects in Shh-signaling with Chmp1a shRNA as shown in our data could provide an 
explanation for the cerebellar hypoplasia in patients lacking functional CHMP1A. Shh is a key 
mitogen for cerebellar granule cell proliferation (Wechsler-Reya et al., 1999; Hatten et al., 2011). 
Purkinje cells release Shh to control proliferation of the granule cell progenitors (Dahmane et al., 
1999; Wang et al., 2001), and levels of Shh control the complexity of cerebellar foliation 
(Corrales et al., 2006). However, defects in Wnt3 also contribute to cerebellar patterning, and 
could contribute to the patient phenotype without invoking Shh. During the final maturation of 
Purkinje cells, elaborate dendritic arbors form trophic synapses on granule cells, and this process 
of crosstalk between the granule cells and Purkinje cell appears to involve Wnt3 (Salinas et al., 
1994; van Amerongen et al., 2006).
 In summary, we provide in vitro evidence that knockdown of Chmp1a disrupts both Wnt- 
and Shh-induced transcriptional pathways, and that these effects may contribute to the cortical 
and cerebellar phenotype in patients harboring CHMP1A mutations through its cytoplasmic role 
in MVB formation. These effects may be entirely independent from the role of Chmp1a in 
regulation of proliferation through Bmi1-Ink4a.
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Chapter 4:
Genetic architecture and asymmetries of human polymicrogyria
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Introduction
 Polymicrogyria (PMG) is a highly epileptogenic congenital malformation of cortical 
development characterized by the appearance of excessive small folds of the cerebral cortex on 
neuroimaging, and pathological evidence of abnormal neuronal organization. Most patients with 
polymicrogyria present with epilepsy in childhood - often refractory to standard medical 
treatment - along with intellectual disability, motor dysfunction and speech disturbances (Inder et 
al., 1999). The severity of the clinical presentation and age at presentation depend mostly upon 
the extent of cortical involvement (Barkovich, 2010). 
 Polymicrogyria appears to be a highly heterogeneous disorder in terms of its 
pathogenesis, distribution, and pathological and radiographic features. It can affect variable 
portions of the cerebral cortex, and may be unilateral, bilateral, or asymmetrical. The most 
common location is around the sylvian fissure, particularly the posterior aspect of the fissure 
(Leventer, 2007). However, any part of the cerebral cortex, including the frontal, occipital, and 
temporal lobes, can be affected (Guerrini et al., 1997). Polymicrogyria may be an isolated 
malformation or it may be associated with other brain malformations, such as corpus callosum 
agenesis and hypogenesis, cerebellar hypoplasia (Barkovich et al., 2007), or periventricular or 
subcortical heterotopia (Wieck et al., 2005). Affected patients range from microcephalic, to 
normocephalic, to macrocephalic (Dobyns et al., 2008).
 From its histopathological pattern, polymicrogyria is considered a disorder of cortical 
organization, since the disruption is consistent with perturbations to late-stage neuronal 
migration. However a definitive etiology remains unclear (Barkovich et al., 2005). Evidence for 
both genetic and non-genetic etiologies exists. Polymicrogyria can be induced by in utero 
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ischemic events and can be seen secondary to congenital infections such as cytomegalovirus 
(Levine et al., 1974). Polymicrogyria has a range of histologic appearances, all having in 
common a disorganization of the normal six-layered lamination of the cortex and fusion of the 
molecular layer across sulci (Barkovich et al., 1992). 
 Despite strong evidence for the heritability of polymicrogyria, their extreme 
heterogeneity and the confounding influence of non-genetic contributing forces (such as 
infection and ischemia) makes identifying genetic causes difficult. Nevertheless, using highly 
informative multiplex families, and organizing cases into clinical and radiographic subtypes in 
the hope of finding a cohort that shares a molecular defect, allows for a way forward in 
elucidating the genetics of this complex disease.
Genes and loci for polymicrogyria
 Polymicrogyria has been associated with several chromosomal deletion and duplication 
syndromes including the common deletion 22q11.2 (DiGeorge) syndrome (Robin et al., 2006; 
Dobyns et al., 2008). A genetic basis for some forms of polymicrogyria has been proposed based 
on reports of familial recurrence consistent with autosomal dominant, autosomal recessive, or X-
linked inheritance (Guerreiro et al., 2000). Three loci of interest for the bilateral perisylvian form 
of polymicrogyria have been identified on chromosome X (Villard et al., 2002; Santos et al., 
2008), yet only one polymicrogyria patient mutation has been identified for any gene in these 
loci, the SRPX2 gene at Xq22 (Roll et al., 2006).
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 Autosomal recessive polymicrogyria genes include GPR56, RAB3GAP1 and RAB3GAP2 
(all three associated with bilateral fronto-parietal polymirogyria), TUBA1A (associated with 
perisylvian polymicrogyria), and LAMC3 (associated with occipital polymicrogyria), among 
others (reviewed in Manzini and Walsh, 2011). Mutations in TUBB2B have recently been 
identified in four patients with asymmetric polymicrogyria, and functional studies suggest that 
this gene is required for neuronal migration (Jaglin et al., 2009). The identification of these genes 
offered the tantalizing possibility that the heterogeneous polymicrogyrias could be discrete 
entities in which a single genetic lesion correlates with a specific regional disruption in the 
cortex. Other more severe syndromes in which polymicrogyria is one feature have been 
described with mutations to EOMES, PAX6, COL18A1, and KIAA1279 (Table 4.1), but still the 
vast majority of cases of polymicrogyria have yet to be explained by specific gene mutations. On 
the basis of these findings we hypothesized (1) that there are still many additional genetic causes 
for this genetically heterogeneous and epileptogenic malformation, and (2) that the identification 
and study of new genes for well-phenotyped, regionally specific forms of polymicrogyria will 
shed further light on the intricate and detailed processes that govern the organization of the 
human brain and lead to epilepsy when they are perturbed.
Asymmetric polymicrogyria
 The most common form of polymicrogyria is that which occurs in the perisylvian 
regions, accounting for 60-70% of all cases (Leventer et al., 2001). Approximately 80% of 
perisylvian polymicrogyria is bilateral, though in the asymmetric cohort there are a few cases 
that are strikingly unilateral (Guerrini, 2010; Chang et al., 2006). The Sylvian fissure is a 
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particularly interesting structure that demarcates the separation between the temporal, frontal, 
and parietal lobes. The fissure forms between the inferior frontal lobe and superior temporal 
lobe. In a process called “operculization”, the developing insular cortex indents and is 
surrounded by the developing frontal, temporal, and parietal lobes (Quarello et al., 2008). 
Identifying genes that regulate the intricate biophysical steps involved in the folding of the 
Sylvian fissure may yield insight into the developmental biology human brain left-right 
asymmetry. 
 We focused our attention on the asymmetric cases within our collection of familial, or 
suspected familial, polymicrogyrias. We show that the asymmetric and unilateral cases are 
strongly biased towards right-predominant polymicrogyria. Using whole-exome sequencing in 
patients with polymicrogyria, we identify rare mutations in two primary microcephaly genes, 
ASPM and WDR62. Interestingly, some of these patients lack profound microcephaly, suggesting 
heretofore underappreciated pleiotropic effects of these centrosomal genes
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Methods
Human studies
All human studies were reviewed and approved by the institutional review board of the 
Children’s Hospital Boston, Beth Israel Deaconess Medical Center, and local institutions.
Patient recruitment 
Consanguineous families were collected through the Children’s Hospital Boston Brain 
Development and Genetics clinic, with referral centers in Turkey, Saudi Arabia, Kuwait, United 
Arab Emirates, Egypt, Oman, Jordan, and Pakistan. Inclusion criteria included a diagnosis of 
polymicrogyria or perisylvian syndrome by a neurologist or neuroradiologist, and multiple 
affected children and/or suspected consanguinity (first or second cousins). 54 families were 
recruited in total. Patients were phenotyped using staging criteria by A.J.B. We performed more 
extensive analysis of selected families that were most informative genetically. 
Genome-wide linkage and homozygosity scans
Genome-wide SNP screens were performed at the Broad Institute and Dana Farber 
Institute. Families were genotyped using Affymetrix 500K (NspI/Sty) or Affymetrix 6.0 
microarrays. Single- and multipoint LOD scores were calculated using Allegro, assuming a 
recessive mode of disease inheritance, full penetrance, and a disease allele frequency of 0.0001. 
Runs of homozygosity were determined using custom Perl scripts, allowing for no more than 2 
consecutive heterozygous SNPs in a run and 3 heterozygous calls in every 10 consecutive SNPs. 
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Intervals homozygous for the same haplotype and shared by all affected individuals were used to 
narrow the locus in each family.
Copy number variant analyses
CNV analyses were performed using Birdsuite, PennCNV, Nexus and Affymetrix 
Genotyping Console. Criteria for CNV calling included the intersection of two or more 
algorithms, 10 or more probes (15 for Affymetrix 6.0 samples) and size >100 kb.  Samples with a 
very large number of calls (120) were rejected, as they are typically the result of poor DNA 
hybridization. After CNV calling, results were compared to a reference catalog generated from 
1258 HapMap samples and filtered to remove common variants. 
Whole exome sequencing and data analysis
DNA samples were sequenced at the Broad Institute or Axeq. Whole blood DNA was 
subject to barcoded exome capture (SureSelect v2, Agilent Technologies, Inc., Santa Clara, CA) 
and single-end sequencing (Illumina, read length of 36 bp). Whole exome sequence was obtained 
on 35 affected children, with a mean target coverage of 85.6% at >=20X and a read depth of 
158X. 
Reads were processed using Picard and aligned using BWA to hg19. Variant calling was 
performed with the GATK software suite at the Broad Institute. Variants were filtered according 
to standard GATK variant quality score recalibration thresholds. On average 38,148 SNPs and 
5,569 indels were called per sample. Variants were then annotated more fully with respect to 
predicted molecular effect, pathogenicity (SIFT, PolyPhen2) and presence in public databases 
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using Annovar and a series of custom scripts (Kumar et al., 2009; Adzhubei et al., 2010). 
Reported pathogenic variants were confirmed by Sanger sequencing.
Sanger resequencing
Sequencing by capillary electrophoresis was performed according to standard molecular 
biology practices at SeqWright, Inc. (Houston, Texas).
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Results
Asymmetric perisylvian polymicrogyria is biased towards right-predominant cases
 The clinical presentation of right-sided polymicrogyria does not appear to be more severe 
than the equally disrupted left-sided malformation, therefore ascertainment bias does not appear 
to confound an analysis of the asymmetries of perisylvian polymicrogyria. From our patient 
cohort that received high-quality MRIs, in which the extent of the malformation could be 
measured within and between each hemisphere, there appears to be a strong right-sided bias 
(Figure 4.1a-g). This bias is evident in those cases where the polymicrogyria was bilateral but 
asymmetric in its severity, with approximately a 3:1 ratio between right-predominant and left-
predominant cases (Figure 4.1h, p < 0.01 using a two-tailed Pearson’s chi-squared test). This 
ratio is even more biased towards the right side in the unilateral cases (Figure 4.1h; p < 0.001 
using a two-tailed Pearson’s chi-squared test).
Whole-exome sequencing identifies novel variants to known PMG genes 
 Since the presence of recurrent inherited and de novo CNVs could potentially confound a 
recessive analysis, we excluded families harboring rare, large, CNVs. Using whole-exome 
sequencing in the remaining cohort, we processed the samples using a pipeline described in the 
methods and schematized in Figure 4.2. We first screened known polymicrogyria genes under 
non-recessive inheritance, annotating 14 genes with evidence linking them to polymicrogyria 
(Table 4.1). Since we sought to define the contribution of rare, highly penetrant risk alleles to 
polymicrogyria in our cohort, we prioritized variants based on rarity (minor allele frequency, 
MAF <1% in known databases and our own dataset of 831 Middle Eastern individuals), 
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predicted protein effect (nonsense/frameshift, splice-altering, missense), and inheritance pattern 
(de novo, or segregating in the family in a manner consistent with X-linked or autosomal 
dominant inheritance). We first filtered for variants in known PMG genes, in regions of large 
haplotype blocks shared by all the affected individuals in the family (blocks determined from 
Affymetrix SNP arrays). From this analysis we identified novel variants in five different genes 
previously linked to polymicrogyria, that segregated with disease in the pedigrees (Table 4.2). 
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Figure 4.1
Examples of right-sided unilateral polymicrogyria.
(a-g) Representative axial images from selected cases of right-sided unilateral polymicrogyria. 
Regions of polymicrogyria are outlined in red.
(h) Classification of the asymmetric polymicrogyria cases with high-quality MRI into bilateral 
and unilateral, and right-sided or left-sided predominant. 
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Figure 4.2
Schematic of whole-exome sequencing pipeline and variant annotation.
The internally developed pipeline for whole-exome variant analysis begins with patient consent 
and recruitment, and DNA collection from whole blood. An Affymetrix SNP array (6.0) is 
performed to generate linkage information in the familial cases, and to rule out any cases for 
high-throughput sequencing if a large, rare CNV is detected. Whole-exome sequencing was 
performed at Axeq and the Broad Institute on the Illumina pipeline. Raw data was batch 
processed for alignment and annotation. The variants were intersected with public databases, 
including dbSNP, 1000 Genomes, the NHLBI Exome Variant Server (EVS), Complete Genomics 
whole genomes, as well as our internal database of 831 exomes.
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Table 4.1
Known genes and loci associated with polymicrogyria.
Locus Gene Inheritance Reference
12q13.12
6p25
16q24.3
21q22.3
3p21.3-p21.2
16q21
10q22.1
9q34.12
11p13
2q21.3
1q41
22q11.2
19q13.12
Xq21.33-q23
1p36.3
4q21.21-22.1
6q26-qter
22q11.2
2p16.1-23
TUBA1A Dominant Jansen et al., 2011
TUBB2B Dominant Jaglin et al., 2009
TUBB3 Dominant Poirier et al., 2010
COL18A1 Recessive Paisán‐Ruiz et al., 2009
EOMES Recessive Baala et al., 2007
GPR56 Recessive Piao et al., 2006
KIAA1279 Recessive Brooks et al., 2005
LAMC3 Recessive Barak et al., 2011
PAX6 Recessive Mitchell et al., 2003
RAB3GAP1 Recessive Morris-Rosendahl et al., 2010
RAB3GAP2 Recessive Borck et al., 2011
TUBA8 Recessive Abdollahi et al., 2009
WDR62 Recessive Yu et al., 2010; Bilguvar et al., 2010; Nicholas et al., 2010
SRPX2 X-linked Roll et al., 2006
Deletion Dobyns et al., 2008
Deletion Dobyns et al., 2008
Deletion Dobyns et al., 2008
Deletion Dobyns et al., 2008
Duplication Dobyns et al., 2008
A list of genes and loci associated with polymicrogyria, their observed inheritance pattern, and 
references from the literature.
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Table 4.2
Identified rare variants to known PMG genes.
The exome data from our cohort was screened for rare variants to the list of known genes in 
Table 1.  In cases where multiple patients were sequenced within the family, the variants shown 
were shared across all affected individuals, with an allele frequency < 1% in all the databases 
listed. Chr = chromosome; Position = basepair position of the variant (hg19); Ref = reference 
base (hg19); Obs = observed variant; Homozygous = Y if the variant is homozygous, N if 
heterozygous; AA Change = predicted amino acid change for that variant in the given transcript; 
1000G = allele frequency in the 1000 Genomes database; NHLBI = allele frequency in the 
NHLBI Exome Variant Server; CG69 = allele frequency within 69 whole genome sequences 
from Complete Genomics; Lab AF = allele frequency within the 831 whole exomes in the 
internal Walsh Lab database; SNV = single nucleotide variant; SIFT = prediction algorithm from 
the J. Craig Venter Institute for the severity of nonsynonymous polymorphisms (< 0.05 
considered damaging) (Kumar et al., 2009); PolyPhen2 = another prediction algorithm (higher 
score is better) (Adzhubei et al., 2010).
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Table 4.2 (Continued)
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TUBB2B
 FC-500 is an American family with two affected boys with right unilateral PMG and left 
hemiparesis. The parents denied consanguinity. The PMG of boy patients involves the lateral 
right hemisphere with sparing of the frontal and occipital poles, reduced white matter in the right 
hemisphere, and a small right peduncle and pons. Interestingly, both also shared a slight 
asymmetry in the size of the caudate. Both patients harbored rare heterozygous variants to 
TUBB2B that were not found in 1000 Genomes, the NHLBI Exome Variant Server, or in our 
internal lab exome database. The variant results in a missense change in a highly conserved 
residue, p.N414S, and is predicted to be deleterious by SIFT and PolyPhen2 prediction 
algorithms (Table 4.2). A list of all the rare variants shared by the two affected patients is listed 
in Table 4.3.
 TUBB2B has been identified as a gene for asymmetrical PMG (Jaglin et al., 2009), 
however the severity of the malformation in the published cases is much higher than in FC-500, 
which appears to have a unilateral right-sided distribution, rather than one in which both sides 
are severely affected but one side greater than the other (as seen in the previously published 
cases).
SRPX2
 PMG-14501 is a consanguineous pedigree of Kuwait origin with one affected boy with 
right-sided perisylvian polymicrogyria. Exome sequencing identified 26 rare homozygous 
variants, including nonsense mutations to HEXDC and HNRNPA1L2 (Table 4.4). No loss-of-
function mutations to these genes were identified in any of our other PMG exomes. In addition, a 
112
missense variant (p.S150F) was found in SRPX2, a known bilateral perisylvian PMG gene, with 
one patient mutation reported (p.Y72S) (Roll et al., 2006) (Table 4.2). In that report, the patient 
had an asymmetric malformation, with the PMG more severe on the left (Roll et al., 2006).
 
RAB3GAP2
 PMG-16100 is a Moroccan consanguineous pedigree with diffuse bilateral 
polymicrogyria. Exome sequencing identified 19 homozygous rare variants, including a 
frameshift to GPR179, and no compound heterozygous candidate variants (Table 4.5). A 
homozygous missense change to a highly conserved residue in RAB3GAP2 was predicted to be 
severely damaging by both SIFT and PolyPhen2 algorithms (p.P527L) (Table 4.2). A single case 
of an in-frame deletion of three amino acids to RAB3GAP2 is  reported to cause Warburg Micro 
syndrome (the predominant genetic lesion is to RAB3GAP1) (Borck et al., 2010). Bilateral 
fronto-parietal polymicrogyria is a noted feature of Warburg Micro syndrome (Aligianis et al., 
2005).
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Table 4.3: FC-500 rare variants shared between FC-501, 502.
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Table 4.4: PMG-14501 homozygous rare variants and proband MRI.
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Table 4.5: PMG-16101 homozygous rare variants.
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WDR62
 In addition to filtering for homozygous variants, we also searched for candidate 
compound heterozygous changes by looking for genes with two or more rare variants. We 
identified two families harboring rare compound heterozygous variants to WDR62. 
 PAC-1500 is a mixed ancestry pedigree from Pennsylvania, with three affected children 
with right-sided unilateral PMG, two unaffected siblings, and unaffected parents (Figure 4.3a,b). 
Haplotype analysis combined with exome sequencing converged on only one recessive candidate 
gene, with two variants to WDR62. The first variant is a three basepair deletion (p.251_252del, 
removal of a conserved histidine residue), and the second is a missense change of another 
conserved residue (p.R1521W) in the second to last amino acid residue of the peptide (Table 4.2; 
Figure 4.3a). All three affected patients have head circumferences within the normal range 
(Figure 4.3b,c).
 PMG-17800 is also a mixed ancestry pedigree from the United Kingdom, with two 
children (one boy, one girl) affected with posterior predominant bilateral perisylvian 
polymicrogyria, and one unaffected sister. Both affected children had delayed speech and feeding 
difficulties. The parents are unaffected. As expected from an outbred pedigree, the two affected 
individuals share no homozygous variants. Screening for compound heterozygous variants, only 
one gene met the criteria for two or more variants in both affected individual, WDR62 (Table 
4.2). The two variants, p.G494R and p.T575M, are in highly conserved residues (Table 4.2). 
Haplotype analysis and Sanger sequencing (data not shown) confirmed that both alleles 
segregate together with disease. As with PAC-1500, both patients in PMG-17800 are reported to 
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be normocephalic, with PMG-17801 and PMG-17804 having birth head circumferences of 34 
cm (20th percentile) and 33 cm (10th percentile), respectively.
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Figure 4.3
Right-sided PMG segregates with a compound heterozygous mutation to WDR62.
(a) Pedigree of PAC-1500 and Sanger sequencing traces from WDR62 variants identified on 
whole-exome sequencing confirm the segregation and phase of the compound heterozygous 
haplotype. The three basepair deletion allele on exon 7 and the point mutation on exon 32 are 
both highlighted in red. (b) T1-weighted axial MRI images from PAC-1501, 1502, and 1503 are 
shown below their corresponding pedigree symbol. Arrowheads indicate the extent of the 
unilateral right-sided polymicrogyria in each patient. (c) Head circumference data from each 
affected individual along with the age- and gender-adjusted percentile shows all three patients to 
be within the normal range.
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Figure 4.3 (Continued)
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ASPM
 Though not included in our screening list for known polymicrogyria genes, there is a case 
report of prematurely truncating frameshift ASPM mutation associated with unilateral PMG with 
microcephaly (Passemard et al., 2009). We have identified two additional novel truncating 
mutations in ASPM in two families with bilateral perisylvian polymicrogyria with microcephaly.
 MC-23100 is a Kuwaiti pedigree with multiple loops of consanguinity (Figure 4.4). One 
branch of the family has three affected individuals with bilateral perisylvian polymicrogyria and 
severe microcephaly (head circumference -8 to -9 standard deviations from the mean for age and 
gender) (Figure 4.4). Two of these patients are identical twin girls (MC-23101, MC-23102), and 
the other is a boy (MC-23103). The parents are clinically unaffected. In another branch of the 
family, there is one affected girl with severe microcephaly without polymicrogyria or the clinical 
manifestations of perisylvian syndrome (MC-23106). Exome sequencing in MC-23102 and 
MC-23106 reveals only one shared homozygous rare variant that segregates with disease, a 
nonsense mutation to ASPM (p.Q2673X) (Table 4.2). 
 PMG-5600 is a pedigree with from Germany with two affected children (one boy and one 
girl) with diffuse bilateral polymicrogyria. The parents are unaffected and deny consanguinity. 
Microcephaly is not apparent from the MRI (data not shown), however birth head 
circumferences were not ascertained. Unexpected, a rare homozygous variant in ASPM was 
shared between both affected individuals, a frameshift deletion of two basepairs at position 
197,071,034 on chromosome 1 (Table 4.2). No other shared homozygous variants passed the 
filtering criteria. There are two candidate compound heterozygous genes, each harboring two 
variants in both PMG-5601 and 5602. GOLGA6L6 (p.R541W and p.E474X) and DDX60 
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(p.G79E and c.2671-1G>A, predicted to disrupt splicing at exon 21). Phasing and segregation of 
both alleles was not confirmed.
Figure 4.4
Pedigree structure of MC-23100, with proband MRI.
Black arrowheads indicate regions of polymicrogyria on coronal T1-weighted MRI for 
MC-23102. Double lines indicate consanguineous relationships.
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Discussion
 Previous work has suggested that unilateral perisylvian polymicrogyria is a distinct 
familial syndrome (Chang et al., 2005), and other groups have commented on the frequently 
asymmetric appearance of bilateral perisylvian polymicrogyria, but a statistical case has never 
been made (Leventer et al., 2010). Our data from a cohort of both familial mulitplex and simplex 
cases suggests that bilateral perisylvian polymicrogyria is somewhat biased towards a right-
predominant pattern, and that unilateral polymicrogyria is substantially skewed towards a right-
sided presentation (Figure 4.1). If we posit that the unilateral cases are hypomorphic 
presentations of a more severe syndrome, this suggests that the right perisylvian region is 
selectively vulnerable to developing PMG. Population-averaged, surface- and volume-based 
radiographic morphometry has demonstrated prominent left–right asymmetries in and near the 
Sylvian fissure (Van Essen, 2005). The sulcul depth and extent of the Sylvian fissure are the most 
variable features between and within individuals (Van Essen, 2005). Therefore, it seems likely 
that this region of developmental instability is particularly vulnerable to focal cortical 
malformations.
 The identification of compound heterozygous variants in WDR62 in patients with 
polymicrogyria was surprising because these patients lacked microcephaly. Compound 
heterozygous changes to WDR62 have been reported in a familial case of bilateral perisylvian 
polymicrogyria with microcephaly and simplified gyral patterning (Murdock et al., 2011). The 
spectrum of WDR62 phenotypes is remarkably variable (Yu et al., 2010; Bilguvar et al., 2010; 
Nicholas et al., 2010), and there appears to be no genotype-phenotype correlation, since almost 
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all mutations are truncations that are predicted to completely abrogate protein function. Some 
missense mutations in WDR62 are responsible for milder form of microcephaly, with less severe 
reduction of brain size and less evidence for abnormal brain histology (Bilguvar et al., 2010; 
Nicholas et al., 2010; Yu et al., 2010). Nevertheless, the core phenotype of WDR62 has always 
involved microcephaly (Figure 4.5), and this has steered the biological understanding of its key 
role towards one of facilitation of neural progenitor proliferation through maintenance of the 
mitotic spindle. In both PAC-1500 and PMG-17800, none of the affected patients show evidence 
of microcephaly at birth or later in life (Figure 4.3). This suggests that in the patients with these 
particular compound heterozygous haplotypes, that only specific domains of WDR62 may be 
affected, and this hypomorphic presentation does not affect proliferation, but rather impacts more 
subtle roles of WDR62 in later-stage cortical organization. For the first time we show that the 
core phenotype of WDR62 does not necessary require microcephaly.
 ASPM (abnormal spindle microcephaly) is the gene most commonly mutated in human 
microcephaly (Bond et al., 2002, 2003; Nicholas et al., 2009). Like Wdr62, Aspm protein 
localizes to the mitotic spindle and appears essential for normal mitotic spindle function (Fish et 
al., 2006; Kouprina et al., 2005). All but one of the almost one hundred reported mutations in 
ASPM represent truncations (Gul et al., 2006; Bond et al., 2002; Kousar et al., 2010; Nicholas et 
al., 2009), and like truncations in WDR62, are found throughout the coding region of the gene 
with no apparent correlation to disease severity. We show that certain rare truncating mutations 
to ASPM that are seemingly indistinguishable from any other truncation can present with 
bilateral perisylvian polymicrogyria, in addition to microcephaly (Table 4.2). This variability is 
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present even within the same family, where one branch of the family lacked any detectable PMG 
(Figure 4.4). 
 In summary, we used whole-exome sequencing in a cohort of polymicrogyrias, and 
identified novel variants in several known PMG genes but also in primary microcephaly genes 
ASPM and WDR62. This expands the clinical and radiographic phenotype of ASPM and WDR62 
mutations, and suggests that future gene discovery in polymicrogyria cases should screen for 
variants from a broad category of genes involved in cortical development, since missense or 
hypomorphic mutations can lead to different malformations that are not easily recognized as 
allelic. 
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Figure 4.5
PAC-1500 clinical presentation varies from the core WDR62 phenotype.
A schematic of the WDR62 gene locus, with exons drawn as black boxes scaled to their relative 
length (intron distances not to scale). Above, WDR62 mutations identified within our laboratory 
and in the literature are annotated relative to their position in the gene locus. The two WDR62 
alleles identified in PAC-1500 are annotated below the gene schematic. The core clinical 
phenotype of patients with WDR62 mutations is listed and aligned with their corresponding 
variant. There is significant variability in the phenotype, but microcephaly with simplified gyral 
patterning is seen all previously identified cases, but not in PAC-1500.
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Discussion
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  The scope of this dissertation spans both ends of human disease genetics: extremely rare 
syndromes with low disease heterogeneity (such as microcephaly with pontocerebellar 
hypoplasia), and more prevalent, highly heterogeneous syndromes (such as polymicrogyria). The 
differences in the disease heterogeneity dictate different gene discovery strategies. In the rare 
syndromes, traditional techniques of linkage mapping in highly informative consanguineous 
pedigrees is possible because the low heterogeneity of the syndrome allows us to pool linkage 
scores across multiple families to arrive at a statistically significant locus. We discovered 
CHMP1A by combining the LOD scores of two pedigrees from different parts of the world, on 
the basis of their shared phenotypic distinctiveness. This is less fruitful in high-heterogeneity 
disease, since the inherent disease variability makes it difficult, if not impossible, to claim a 
priori that two pedigrees share the same molecular defect based on the phenotype. We attempted 
to focus our attention on the unilateral polymicrogyria cases in the hope that these malformations 
were allelic. That turned out not to be the case, but it was a pragmatic decision that could 
reasonably be made again. The era of high-throughput sequencing has increased the speed and 
decreased the cost of analyzing variants, and eventually will make the work of subcategorizing 
heterogeneous diseases into phenotypic groups increasingly moot. In the not-so-distant future, 
the initial categorizations will be made from the genotype, not the phenotype.
 In Chapter 2 we identify a new gene for human microcephaly, CHMP1A. Because we had 
the ideal situation of highly informative families with a very rare disease, discovery of the 
variants was challenging but straightforward, leaving more opportunity to probe the biology of 
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the gene. We were struck by how similar the Bmi1-/- mouse brain phenotype resembled the rare 
constellation of morphological defects seen in our patients. This led us to hypothesize a 
mechanistic connection between CHMP1A and BMI1, and the bulk of Chapter 2 seeks to 
demonstrate through analysis of expression and zebrafish models that INK4A expression is 
downstream of CHMP1A and that disruption of BMI1-INK4A could explain the proliferative 
defects seen in the cortex and cerebellum. 
 CHMP1A is fascinating protein. It has two seemingly non-overlapping functions: a 
cytoplasmic role in ESCRT-III-mediated regulation of multivesicular bodies, and a role in the 
nuclear matrix regulating chromatin structure. As an aside, both of these functions were initially 
identified by the same research group in back-to-back papers in the same journal (Stauffer et al., 
2001; Howard et al., 2001). In Chapter 3, rather than interrogating one specific molecule such as 
BMI1, we explored the possible non-nuclear roles of CHMP1A. We utilized the Chmp1a gene-
trap mouse to characterize the loss-of-function phenotype in vivo, and tested for defects in Wnt 
and Shh pathways in vitro. The reduction in Wnt- and Shh-stimulated transcriptional activity in 
the presence of Chmp1a knockdown appears to support the proposed model of ESCRT-III 
mediating transduction of both Wnt and Shh pathways via GSK3 (Taelman et al., 2010; Kim et 
al., 2009).
 In Chapter 4 we step into the breach of complex genetics with a search for genes for 
polymicrogyria using whole-exome sequencing. Here, pragmatic compromises needed to be 
made. We do not have highly informative families, so our filtering strategies need to be 
sophisticated to winnow down the list of variants to a manageable subset. Most of our 
polymicrogyria pedigrees are non-consanguineous, hence we need to build a pipeline to screen 
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for possible compound heterozygous candidate genes. We sought a screening approach, to first 
rule out patients that harbored rare, deleterious variants to previously published PMG genes. Our 
results identify novel rare variants, including compound heterozygous haplotypes, to TUBB2B, 
RAB3GAP2, and SRPX2. Interestingly, we also uncover variants to two primary microcephaly 
genes, ASPM and WDR62, that segregate with disease in multiplex families and are predicted to 
be deleterious. This expands the phenotypic spectrum of these two genes, and suggests roles 
beyond neural progenitor proliferation. 
Proliferation and patterning defects converge on role in OSVZ progenitors
 One curious feature of WDR62 and ASPM from our data is that rare mutations appear to 
present with polymicrogyria without severe microcephaly, despite most published mutations 
presenting with profound microcephaly, often without polymicrogyria. One way to reconcile 
these effects is to propose that these genes may regulate neural progenitor proliferation in more 
subtle ways. Cortical size reduction in the Aspm knockout mice has been modest compared to the 
human phenotype (Pulvers et al., 2010; Manzini & Walsh, 2011), and an early look at a Wdr62 
gene-trap line also appears to show only a mild reduction in cortical volume (Tim W. Yu, 
personal communication). It is possible that though these genes are present at every mitotic 
spindle and regulate proliferation, their effect is most pronounced in a class of stem cells that are 
not abundant in the mouse, namely outer subventricular zone (OSVZ) progenitors (Lamonica et 
al., 2012). 
 Outer radial glia are characterized by a long radial process that reaches the pial surface, 
with the soma in the OSVZ, and a lack of an apical process (Hansen et al., 2010).  A thick OSVZ 
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is only seen in gyrencephalic brains (Kriegstein, et al., 2006). One model for the role of WDR62 
and ASPM is that they regulate the organization and proliferation of progenitors in the OSVZ. 
Mild or hypomorphic effects would present with defects in gyrification without overt changes to 
overall brain size. And perhaps the most hypomorphic alleles would present with gyrification 
defects where the brain is biophysically most vulnerable and variable: in the Sylvian fissure (Van 
Essen, 2005). Severe effects on these genes would present with microcephaly because the OSVZ 
expands rapidly to become the dominant germinal layer in the neocortex (Lui et al., 2011). This 
mechanism of microcephaly would be of a different route than microcephaly secondary to 
disruption of ventricular radial glia proliferation (with MCPH, CEP152, etc.), but the effect may 
not be distinguishable radiographically.
CHMP1A in tumor biology 
 The in vitro data showing a reduction in Wnt- and Shh-stimulated transcription with 
Chmp1a shRNA, immediately suggests exploring the role of CHMP1A in human or mouse 
tumors. Medulloblastoma is the most common malignant brain tumor in children (Marino, 2005), 
and recent molecular subgrouping of a large array of medulloblastomas identified the critical 
signature of WNT and SHH disruption in over 30% of tumors (Cho et al., 2011). Inactivation of 
the Patched receptor, or activation of Smoothened, or overexpression of Shh itself was sufficient 
to induce tumors in mice (Vaillant et al., 2009). In fact, the nexus of WNT and SHH pathway 
disruptions in these tumors is suspicious for a more proximate role of GSK3. It is possible that 
ESCRT-III function plays a critical and necessary role in allowing these tumors to propagate.
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Pleiotropy and heterogeneity in human disease
 What connects CHMP1A to our findings with WDR62 and ASPM is that in all three 
examples we have a gene that appears to have multiple roles in brain development. Pleiotropy 
has been suggested to play a key role in generating a complex brain (Kovas et al., 2006), and 
pleiotropic networks have been identified in nervous system function (Chesler et al., 2005). It 
should perhaps not be surprising that nature would map multiple functions onto each gene, to 
maximize the diversity capable from a limited set of genes. As we identify more alleles for 
syndromes that unexpectedly map back to primary microcephaly genes, we will begin to clarify 
functional domains or critical residues that mediate specific interactions. This will lead to 
specific hypotheses to genetically and biochemically dissociate the multiple roles of these genes 
in brain development. 
 In fact, elucidation of a pathway from genes identified from exome sequencing may be 
possible from our data. The identification of RAB3GAP2 mutations, and the phenotypic 
similarity of those patients’ MRI to the bilateral fronto-parietal polymicrogyria (BPPP) pattern 
seen with GPR56 and COL18A1 mutations, suggests a possible mechanistic connection between 
these three components. Gpr56 is an orphan G-protein coupled receptor (Piao et al., 2004), for 
which Col3a1 has recently been proposed as a ligand (Luo et al., 2011). Mutations to human 
COL3A1 have not been identified in polymicrogyria, however loss-of-function mutations to a 
paralogous gene, COL18A1, are found in patients with Knobloch syndrome, in which BFPP is 
one radiographic feature (Keren et al., 2009). RAB3GAP2 mutations are associated with Warburg 
Micro syndrome, which also has BFPP (Borck et al., 2010; Aligianis et al., 2005). RAB3GAP2 is 
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involved in the vesicle trafficking of secretory proteins from the Golgi to the plasma membrane 
(Borck et al., 2010). So here we have three proteins with non-overlapping functions and 
subcellular localizations, all presenting with similar loss-of-function brain malformation 
phenotypes. A simple model is that RAB3GAP2 regulates the export of COL18A1 out of the 
cell, to then act as a ligand for GPR56 in regulating further downstream patterning. 
 Recent explosive human population growth over the past ten millenia has resulted in an 
excess of rare variants in the population (Keinan & Clark, 2012). As the world becomes more 
globalized and integrated, genetic admixture increases the probability that offspring will have 
compound heterozygous changes of private mutations, resulting in a range of hypomorphic 
presentations of severe diseases. Though the most severe loss-of-function mutations to GPR56, 
COL18A1, and RAB3GAP2 appear as discrete syndromes, hypomorphic mutations might 
converge on a milder syndrome with BFPP as the shared cardinal feature. And we will recognize 
the allelic nature of the pathway only once we capture the full range of hypomorphic alleles. It 
will be an ongoing challenge to physician-scientists and research centers to integrate the 
subtleties of phenotypic information with the deluge of genetic data to maximize the capacity for 
discovery, while protecting patient privacy.
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